docOhio 2013 CollAboRAti E LAboRAtoR CoNFERENcE
download 
Report Transcription
Ohio 2013 CollAboRAti E LAboRAtoR CoNFERENcE
Ohio 2012 Collaborative Laboratory Conference April 25 – 27, 2012 Crowne Plaza North h Col umbu s,O io 2011 CLC Organization Logos 2011 CLC Organization Logos The The Clinical Clinical Laboratory Laboratory Conference Conference Steering Steering Committee, Committee, Program Program Committees, Committees, AACC-NE AACC-NE Ohio Ohio Section, ASCLS-Ohio and CLMA-First Ohio, Six Rivers and Western Lake Erie Chapters Section, ASCLS-Ohio and CLMA-First Ohio, Six Rivers and Western Lake Erie Chapters are are pleased pleased to extend an invitation to YOU to attend “Ohio CLC 2013: An Exploration of Medical Laboratory to extend an invitation to YOU to attend “Ohio CLC 2013: An Exploration of Medical Laboratory Science." Because the quality of your continuing education can directly affect your professional Science." Because the quality of your continuing education can directly affect your professional development and achievements, this educational conference is designed by YOU for YOU, the clinical development and achievements, this educational conference is designed by YOU for YOU, the clinical laboratory professional. laboratory professional. Who Should Attend: All clinical laboratory practitioners, educators, students, supervisors, Who Should Attend: All clinical laboratory educators, students, supervisors, managers, directors, practitioners, and phlebotomists. managers, directors, and phlebotomists. Benefits of Attending: Review current technologies and learn new techniques Benefits of Attending: current and learn new techniques Review Formulate ideastechnologies for further development Formulate ideas for further development Gain insights into future laboratory practice insights into future laboratory practice Gain Network with your professional colleagues Network with your professional colleagues Enhance your career potential Enhance your career potential Relax . . Learn . . Share . . Have Fun! Relax . . Learn . . Share . . Have Fun! Full Registration: Registration Includes: Full Registration: Registration Includes: Attendance at all conference sessions Attendance at all conference sessions Lunch plus morning and afternoon refreshment breaks Wednesday eveningand dinner Lunch plus morning afternoon refreshment breaks Daily Registration: Wednesday evening dinner All sessions, refreshment breaks and lunch either day Daily Registration: All sessions, refreshment breaks and lunch either day CLC Steering Committee CLC Steering Committee Dustin Bunch, Co-Chair Dustin MelanieBunch, Giusti,Co-Chair Co-Chair Melanie Giusti, Co-Chair Catherine Shaffner, Treasurer Catherine Pam Kin Shaffner, Treasurer Facilities/Social/Hospitality Committee Facilities/Social/Hospitality Committee Laura Hook, Chair Laura Hook, Chair Kay Hanna Kay Hanna Shannon Kern Shannon Kern Pam Allen Kin Nickels Promotion & Publicity Committee Pam Kin, Chair Promotion & Publicity Committee Allen StacyNickels Baker Jane Tester Stacy Baker Eugenio Zabaleta, PhD Jane Tester Eugenio Zabaleta, PhD Program Committee Joe El-Khoury, PhD, Chair Program Committee Stacy Baker (PACE) Joe El-Khoury, PhD, Chair Melanie Giusti Stacy Baker (PACE) Linda Graeter Melanie Giusti Rhonda Perry Linda Graeter Christine Schmotzer, MD Rhonda Perry Eugenio PhD ChristineZabaleta, Schmotzer, MD Greg Attenweiler Pam Kin, Chair DustinAttenweiler Bunch (Cvent) Greg Dustin Bunch (Cvent) Registration Committee Rosanne Kelley, Chair Registration Committee Lisa KubitKelley, (Cvent)Chair Rosanne Jane Tester Lisa Kubit (Cvent) Jane Tester Vendors/Exhibit Committee Allen Nickels, Chair Vendors/Exhibit Committee Paul Labbe Allen Nickels, Chair Paul Labbe Eugenio Zabaleta, PhD 2 This year’s keynote speaker is Nancy Riesz, MBA, MT(ASCP), ACC. She is President of Success Catalyst, a certified Woman Business Enterprise, which she founded in 1993. She has been teaching people how to better work together for 35+ years. This interactive session shares specific skills and provides solutions for working better…. together. In today’s world of rapid technological and social change, teamwork is not a luxury. It is a necessity. Yet, establishing teamwork in the laboratory is not always easy. It requires commitment, cooperation and effort, as well as a willingness to accept and appreciate the uniqueness of others. This presentation will explore ways to develop effective teams at work, to build team unity and strengthen team spirit and ultimately to work together…better with teammates. During the conference, you will have a great opportunity to enhance your learning experience by “Visiting the Vendors” to see and hear about all the newest laboratory instrumentation and testing products. Thursday, May 9 12:00 pm – 5:00 pm Vendor Reception 5:00 pm – 7:00 pm Friday, May 10 9:30 am – 1:30 pm At various times during vendor exhibit hours, there will be door prize drawings – but you must be present to win. Be sure to include some time to visit with our vendors / sponsors during the conference. The CLC organizations are extremely grateful for the generosity from our laboratory industry vendor friends that allow us to provide affordable continuing education to Ohio’s laboratory professionals. A complete listing of vendor exhibitors and sponsors will be provided to all conference attendees. 3 Program Glance Program at at a Glance OHIO OHIO2013 2013COLLABORATIVE COLLABORATIVE LABORATORY LABORATORY CONFERENCE CONFERENCE An AnExploration Explorationof ofMedical Medical Laboratory Laboratory Science Science May May88 –– May May 10, 2013 2013 Wednesday, Wednesday, May May 8 8 12:30 – 5:00 12:30 – 5:00 Registration Registration W1 W1 Point of of Care Testing Point Care Testing 1:001:00 – 2:00 – 2:00 W2 Mass Automationinin MassSpec Spec and Automation MICRO, to be bekidding! kidding! MICRO,you’ve you’ve got to W3 W3 Quality Planning with CMS’ Quality Planning with CMS’ Individualized Plan Individualized QCQC Plan Katharine MT(ASCP),SM, SM, Katharine Roman, Roman, MT(ASCP), CIC(CBIC) CIC(CBIC) SharonEhrmeyer, Ehrmeyer, PhD, (ASCP) Sharon PhD, MTMT (ASCP) Edmunds Z. Z. Reineks, MD,PhD Edmunds Reineks, MD,PhD Sponsored Abbott Sponsored by by Abbott 2:002:00 – 2:30 – 2:30 2:302:30 – 3:30 – 3:30 Refreshment Break Refreshment Break W4 W4 The Power ofof “Like”: The Power “Like”:Social Social Media Marketing AsAs AA Tool Media Marketing ToolFor For Laboratory Business Expansion Laboratory Business Expansion Scottia E. E. Miller, MT (ASCP) Scottia Miller, MT (ASCP) – 4:45 3:453:45 – 4:45 W7 W7 Laboratory Competency Laboratory Competency W5 High Testingin inthe the HighStakes Stakes Drug Testing Neonate Neonate Steven PhD, Steven W. W. Cotten, Cotten, PhD, DABCC, NRCC DABCC, NRCC W8 Howdo do we we get Physicians How Physiciansto to Order the the Right Right Test? Order Test? Ruth Natali, (ASCP),SH Ruth Natali, MTMT (ASCP),SH W6 W6 Evaluation AIDS Gene Therapy Evaluation ofof AIDS Gene Therapy strategies a group of High strategies byby a group of High Schooland and Community College School Community College Students a Science enrichment Students inin a Science enrichment program program Harry Kestler, PhD Harry Kestler, PhD W9 W9 Where the data lives: Data Where the data lives: Data Warehousing, Virtualization andand Warehousing, Virtualization “cloud” in in thethe modern LabLab “cloud”services services modern Eugenio Zabaleta, Zabaleta, PhD Eugenio PhD Arkadiy Kheyfets, MS.Eng, PMP, Arkadiy Kheyfets, MS.Eng, PMP, CISSP, CCDA CISSP, CCDA – 7:00 5:005:00 – 7:00 Dinner Dinner – 9:00 7:007:00 – 9:00 ASCLS-OH Board Board of Directors ASCLS-OH DirectorsMeeting Meeting 4 Program-at-a-Glance Thursday, May912 Thursday, May 8:00-5:30 8:00 – 5:00 Registration Registration 8:00-9:00 8:00 – 8:30 Continental Breakfast Continental Breakfast T11T11 T10T10 Managing PreanalyticalHemoglobin A History of the A1c for the Lean Six Sigma: Variables During Shortages: 2000-2050 Eliminating the 3 D’s (Delay, diagnosis of diabetes Venipuncture Collection Defects, and Deviation) to 8:30 – 9:30 9:00-10:00 Thomas Williams, MD Produce Better, Faster, Sihe Wang, PhD, More Profitable Results Lorraine Tyndell, MS, MT DABCC, FACB (ASCP) Denise M. O’Conner, Sponsored MT(ASCP) by BD Sponsored by Siemens T13 T13 T12T12 of Lab Infection CSI/Reality Effective Educational IsThe the State Current Immunology: Case Modalities in Clinical Allied BusinessControl Model at a Studies of Problem Health Education Strategic Inflection Resolution for Amy Ray, MD,MPH Point? Infections Disease & Craig Clifford, MD, MS Autoantibody Testing Khosrow Shotorbani, MBA, MT(ASCP) Thomas Alexander, Sponsored by ARUP PhD, D(ABMLI) Laboratories 10:00-10:30 Refreshment Break/Visit Vendors 10:30-11:30 Welcome & Keynote Address T14 “Collaboration Celebration” 9:30 – 9:45 Refreshment Break Welcome & Keynote Address T14: Working Together: Moving from Me to We T15 T16 T17 T18 Nancy J. Riesz, MT(ASCP), ACC Surviving Sepsis Preventing and MBA,Using Gel Automation in Blood Lead Testing T182010 T15 T16 Violence Controlling theT17 Blood Bank After Recurrent infections in Pediatric Blood Sparing: whatMA, is this 101 11:45:12:45 No, really, in Screening the Workplace John Ancy, RRT Prenatal AnNeil interdisciplinary anAndrea Adult or a Kid?MLS patient’s blood type?! Hickey, Conway, quality PhD, 11:00 –12:00 improvement initiative to standardize Christine Wensel, MS,MS Cindy Zastrow, DABCC Sponsored by It might be a PID! Clinical and minimize blood sampling and Laboratory Update on Suzanne Bakdash, MD, CGC Instrumentation volumes and reduce pre-analytical Primary Immune Deficiencies Laboratory MPH testing errors 9:45 – 10:45 12:45-2:00 12:00 – 1:30 2:00-3:00 1:30 – 2:30 3:00-3:30 3:30-4:30 2:45 – 3:45 3:45 - 4:00 4:45-5:45 4:00 – 5:00 6:00-8:00 5:00 – 7:00 Lunch/Visit Vendors Thomas S. Alexander, Paula L. Forsythe, MSN, RN, PhD, D(ABMLI) T19 T20 T21 T22 CNS Laboratory Diagnosis of Laboratory Safety: It’s Cancer Stem Cells: Case Studies in Luncheon Bacteremia and not Just for the Rats & Visit Vendors Implications for Clinical Microbiology Fungemia Including Anymore Diagnosis, Prognosis T22 T20 T21 RapidT19 Identification and Treatment Chuck Sylvain, Moving on Up! Fast Track & You Say Apple, I say Leadership in an Health Care Reform Techniques Cindy Zastrow, MS M(ASCP) Career Paths for Orange, An Attempt to emerging healthcare Status Report – 3 years J.Lynne Williams, PhD, Phlebotomists Standardize the Grading since PPACA MLS organization signed into Gerri Hall, PhD Jake Orville of Hematology Morphology law Elaine Ewald & Terrie McManes Sponsored by CompuNet Clinical Catherine Shaffner, T23 T24 T25 T26 Laboratories MLS(ASCP)SH Job Selection Criteria HCG Testing: Epigenetics-It’s not so Automating the Urine T25 After All T24 T26 T23Influence of and the Challenges and Scary Testing Workflow Clinical Laboratory Pediatric Phlebotomy Pitfalls Are These Lab Values A tale of two algorithms: How Reproductive Rotations J.Lynne Evaluating Williams, PhD, Laboratory Kevin Barta, BSof HIV Accurate? diagnosis Laboratories Differ MLS with Laboratory Results and Treponema pallidum from Clinical RandyChristine Gruhlke Schmotzer, BS, CPT, J.Michele Stuart, PhD, MD Sponsored Specimen Quality infection.by Iris Laboratories (NHA) CM MLS (ASCP) Diagnostics T28Medical T29 MS, Sponsored by Mayo Doris J. Baker,T27 PhD, MT Sandra VanVranken, Mario J Marcon,PhD, Organization Business Using HCLD Patient’s DNA to Clinical Presentation Is Cervical Cancer a Laboratories (ASCP), (ABB), MT(ASCP)SH D(ABMM) Meeting(s) CLMA Prescribe Clopidogrel and Diagnosis of Preventable Disease?Emb-Acad. (ACE) (Plavix) Hypercoagulable The role of HPV Refreshment Break/Visit Vendors Conditions Screening Eugenio Zabaleta, PhD T27 IrinaT28 Chibisov, MD BelindaT29 Yen-Lieberman, Critical Values: Cutoffs, Laboratory What Next? I want or Monitoring PhD, SV(ASCP)of Organization Business Communication, and for need a new job! Heparin Therapy Sponsored by Institute Meeting (CLMA) Impact on Care Transfusion Medicine James A. Rowe, MBA, Kathy Shingler, MT(ASCP) by Instrumentation HT, MT (ASCP),FACHE VendorSponsored Reception Christine Schmotzer,MD Refreshment Break/Visit Vendors Paul Labbe, MCLT Laboratory Vendor Reception 5 5 Program-at-a-Glance Thursday, May Friday, May 10 12 8:00-5:30 7:30 – 3:30 Registration Registration 8:00-9:00 7:30 – 8:30 Continental Breakfast ASCLS-OH Member Business Meeting 8:00 – 8:30 9:00-10:00 8:30 – 9:30 10:00-10:30 9:30 – 10:00 10:30-11:30 T10 Managing Preanalytical Variables During F30 Collection Venipuncture T11 T12 Continental A History of the Breakfast/Networking The State of Infection Shortages: 2000-2050 Control F31 F32 Reviewing and Rapid Identification Metabolic Acidosis & Thomas Williams,ofMD Amy Ray, MD,MPH Revising Reference Blood Culture Isolates Metabolic Alkalosis Lorraine Tyndell, MS, MT Intervals: Challenges (ASCP) and Options Ike Northern, MT, Michael D. Patterson, DO Sponsored by BD M(ASCP), MS Amy L. Pyle, PhD, DABCC Refreshment Break/Visit Vendors T13 CSI/Reality Immunology: Case StudiesF33 of Problem Clotting or Bleeding? Resolution for A Case Study-Based Review Infections Disease & of Hemostasis Autoantibody Testing Thomas Alexander, Charity Accurso, PhD PhD, D(ABMLI) MT(ASCP) Refreshment Break/Visit Vendors Welcome & Keynote Address T14 “Collaboration Celebration” F37 F35 F36 F34 T15 of T16 Test Trauma Packs T17 T18 Blood Gases – Let’s Get Controlling Genetic & Massive ASCP Board Surviving Sepsis Preventing and Using Gel Automation in Blood Lead Testing Clinical Send Out Volume Transfusions, What to Certification Controlling Violence the Blood Bank After 2010 Do? Examinations and 11:45:12:45 in the Workplace John Ancy, MA, RRT 10:00 –11:00 Certification Erik Gallion, RCP/RRT Patty Taneja, M.S, CGC Andrea Hickey, MLS Neil Conway, PhD, Maintenance Program Suzanne H. Butch, MA, Cindy Zastrow, MS DABCC Sponsored by CM CM MLS(ASCP) SBB Instrumentation Susan L. Wilkinson, LaboratoryEdD, CM MT(ASCP)SBB 12:45-2:00 F38 F39 Lunch/Visit Vendors F40 F41 Drug Screening Molecular Genetics of T19 for Develop a Business Case T20 T21 A review ofT22 antimicrobial Laboratory Laboratory Safety: It’s Cancer Stem Cells: Case Studies in Pain Diagnosis of Myeloproliferative That Will Get Your susceptibility testing Bacteremia and not Just forand the Rats Implications Clinical Microbiology Management Neoplasms Initiative Fundedfor methods 11:15 –12:15 Fungemia Including Myelodysplastic Anymore Diagnosis, Prognosis – New 2:00-3:00 Rapid Identification andStegall, Treatment Chuck Sylvain, Discoveries Explain Old Binit J. Shah, MD M. Susan MBA, Joel Mortensen, MLT (AMT), Techniques Cindy Zastrow, MS M(ASCP) Observations MHSA, MT(ASCP) PhD J.Lynne Williams, PhD, Sponsored by Meridian J. Lynne Williams, PhD, Gerri Hall, PhD MLS Bioscience MLS 12:15 – 1:30 3:00-3:30 3:30-4:30 1:30 – 2:30 F42T23 Laboratories Job Selectionin Criteria Developing and the Countries: Influence of Clinical Laboratory A Cambodian Rotations Experience Stuart, PhD, B.J.Michele Laurel Elder, PhD CM 2:30 – 2:45 4:45-5:45 2:45 – 3:45 6:00-8:00 Lunch/Vendor Exhibits Refreshment Break/Visit Vendors F45 F43T24 F44 T25 T26 Leukemia Casethe Studies: Vaccination Is Not What to do with the new HCG Testing: Epigenetics-It’s not so Automating Urine the Good, theWorkflow Bad and the Immunization technology andAll Challenges and Scary After Testing Pitfalls Ugly molecular methods in J.Lynne Williams, PhD, Kevin Barta, BS clinical microbiology?! Kathy V. Waller, PhD, Christine MLS MLT Roslyn McQueen, PhD, MLSSchmotzer, Joel Mortensen, MD Sponsored CCRC by Iris (AMT), PhD Diagnostics Sponsored by Meridian T28 T29 Bioscience Organization Business Clinical Presentation Is Cervical Cancer a Meeting(s) CLMA Refreshment Break and Diagnosis of Preventable Disease?Hypercoagulable The role of HPV F49 F46 F47 F48 Conditions Screening Blood Product utilization & iPath touch: The Value Project Management Interferon Gamma Eugenio Zabaleta, PhD IrinaEasy Chibisov, Belinda Yen-Lieberman, Wastage of Touch Imprints in Made plus MD Release Assays (IGRAs) PhD, SV(ASCP) Pathology Fundamentals in the Diagnosis of Sponsored by Institute for Tuberculosis Bob Reigle, MLS (ASCP) Transfusion Samir B. Kahwash, MD M. Susan Stegall,Medicine MBA, Richard B. Clark, PhD, MLS (ASCP) T27 Using Patient’s DNA to Prescribe Clopidogrel (Plavix) MHSA, MT(ASCP) D(ABMM) Vendor Reception Sponsored by Quest Diagnostics 2:30 – 5:00 6 Academic Challenge & Student Mixer 5 SessionAbstracts Abstracts 2013 2013 Session Session Abstracts 2013 Please note that the “level of instruction” is designated as Basic (B), Intermediate (I) Please note the “level instruction” isisdesignated Please notethat that the “levelof of instruction” designatedas asBasic Basic(B), (B),Intermediate Intermediate(I) (I) or Advanced (A) following the title for each session. or orAdvanced Advanced(A) (A)following followingthe thetitle titlefor foreach eachsession. session. W1. Point Of Care Testing (B) W1. W1 W1.Point PointOf OfCare CareTesting Testing(B) (B) Edmunds Z. Reineks, MD, PhD Edmunds Z.Z.Reineks, Edmunds Reineks, MD, PhD Medical Director of Point ofMD, CarePhD Testing and Automated Medical Director Medical DirectorofofPoint PointofofCare CareTesting Testingand andAutomated Automated Chemistry Chemistry Chemistry Cleveland Clinic Cleveland ClevelandClinic Clinic Several case studies in point of care testing will be Several case point testing will Several case studies inin point ofof care testing will be presented to studies illustrate problems orcare issues related to be this presented to illustrate problems or issues related to this presented to illustrate problems or issues related to this type of testing. type typeofoftesting. testing. W2. Mass spec and automation in micro, W2. Mass spec and automation W2 W2. Mass spec and automation micro, you’ve got to be kidding! (I) ininmicro, you’ve you’vegot gotto tobe bekidding! kidding!(I) (I) Katharine Roman, MT(ASCP),SM, CIC(CBIC) Katharine Roman, CIC(CBIC) Katharine Roman,MT(ASCP),SM, MT(ASCP),SM, CIC(CBIC) Manager, Microbiology Laboratory Manager, Microbiology Laboratory Manager, Microbiology Laboratory University Hospitals Case Medical Center University UniversityHospitals HospitalsCase CaseMedical MedicalCenter Center An overview of what MALDI-TOF is, how MALDI-TOF An overview MALDI-TOF is,is,how An overview ofwhat whatmicrobiology MALDI-TOF howMALDI-TOF MALDI-TOF fits into our of current laboratory workflow and fits into fits intoour ourcurrent current microbiologylaboratory laboratoryworkflow workflow and what future state microbiology microbiology laboratories will lookand like what state laboratories will what future statemicrobiology microbiology laboratories willlook looklike like withfuture MALDI-TOF plus total lab automation……...like a with MALDI-TOF with MALDI-TOF plustotal totallab labautomation……...like automation……...likeaa chemistry lab???plus chemistry chemistrylab??? lab??? W3. Quality Planning with CMS’ W3 W3. Quality with CMS’ W3. QualityPlanning Planning with CMS’ Individualized QC Plan (B) Individualized QC Plan (B) Individualized QC Plan (B) Sharon Ehrmeyer, PhD, MT (ASCP) Sharon Ehrmeyer, PhD, MT Sharon Ehrmeyer, PhD, MT(ASCP) (ASCP) Professor, Pathology and Laboratory Medicine Professor, and Professor, Pathology andLaboratory Laboratory Medicine Director,Pathology Clinical Laboratory ScienceMedicine Director, Clinical Laboratory Science Director, Clinical Laboratory Science University of Wisconsin-Madison University UniversityofofWisconsin-Madison Wisconsin-Madison In March, 2012, CMS announced its new QC policy, InInIndividualized March, CMS itsits(IQCP), new policy, March, 2012, 2012,Quality CMS announced announced new QC QC policy, Control Plans based on Individualized Quality Control (IQCP), based on Individualized Quality ControlPlans Planswill (IQCP), based on risk management concepts. IQCP replace (2015?) risk (2015?) risk management concepts. IQCP willreplace replace (2015?) themanagement current EQCconcepts. policy forIQCP sites will using manufacturers’ the current EQC for manufacturers’ the current EQC policy policyAccording for sites sites using manufacturers’ built-in assessments. tousing CMS, IQCP permits built-in assessments. According totoCMS, permits built-in assessments. According CMS,IQCP IQCP permits test sites to customize quality assessments to their test test sites to customize quality assessments to their test sites to customize quality assessments to their test systems and testing situations. This presentationtest will systems testing situations. This presentation systems and testing situations. This presentationwill will discussand IQCP and its development process. discuss discussIQCP IQCPand anditsitsdevelopment developmentprocess. process. Sponsored by Abbott Sponsored Sponsoredby byAbbott Abbott W4. The Power of “Like”: Social Media W4. The of “Like”: W4 W4. ThePower Power ofTool “Like”: SocialMedia Media Marketing As A ForSocial Laboratory Marketing As A Tool For Laboratory Marketing As A Tool For Laboratory Business Expansion (B) Business BusinessExpansion Expansion(B) (B) Scottia E. Miller, MT (ASCP) Scottia E. ScottiaTechnologist E.Miller, Miller,MT (ASCP) Medical IIMT(ASCP) Medical Technologist Medical Technologist The Christ Hospital IIII The TheChrist ChristHospital Hospital As the relatively new idea of social media begins to As ofof social begins toto As the the relatively relatively new idea ideaincreasingly social media media beginsfor expand, it has new become important expand, it has become increasingly important for expand, it has become increasingly important businesses to get on board. Social Media Networking isfor businesses get isis businesses geton onboard. board. Social MediaNetworking Networking no longer toto only present inSocial the Media home, but in the no longer only present in the home, but in the no longer only present in the home, but in the professional world as well. The Power of “Like” Session professional as well. ofof“Like” Session professional world as well.The ThePower Powerfrom “Like” Session will introduceworld social media marketing a laboratory will social from willintroduce introduceand social mediamarketing marketingtactics fromafor alaboratory laboratory perspective, will media include strategic success perspective, and will strategic tactics for perspective, andrecruitment willinclude includetools, strategic tactics forsuccess success such as online tracking your impact, such as online recruitment tools, tracking your such as online tracking establishing yourimpact, impact, going above andrecruitment beyond thetools, competition, going and the establishing goingabove above andbeyond beyond thecompetition, competition, establishing goals, and ways to effectively reach out to potential goals, toto effectively reach goals, and andinways ways effectively reach out out toto potential potential customers the online world. customers customersininthe theonline onlineworld. world. W5. High Stakes Drug Testing in the W5 W5. Stakes W5.High High(B) StakesDrug DrugTesting Testingininthe the Neonate Neonate Neonate(B) (B) Steven W. Cotten, PhD, DABCC, NRCC Steven PhD, StevenW. W.Cotten, Cotten, PhD,DABCC, DABCC,NRCC NRCC Assistant Professor Pathology Assistant Professor Pathology Assistant Professor Pathology Ohio State University Wexner Medical Center Ohio OhioState StateUniversity UniversityWexner WexnerMedical MedicalCenter Center Drug testing in newborns comes with analytical, Drug inin legal newborns with Drug testing testingand newborns comes with analytical, analytical, therapeutic, issues,comes and interpretation of therapeutic, legal interpretation ofof therapeutic, andleft legal issues, and andnurses, interpretation results may and be to issues, physicians, or social results be toto physicians, nurses, oror social results may may be left leftThe physicians, nurses,and social services workers. unique analytical legal services workers. The unique analytical and services pose workers. The of unique analytical and legal legal caveats a variety challenges and therapeutic caveats pose a variety of challenges and therapeutic caveatsfor pose a variety of challenges andresults therapeutic issues providers because laboratory can issues because can issues for for providers providersnewborns because laboratory laboratory results can potentially remove from theirresults biological potentially remove newborns from their biological potentially remove newborns from their biological parents. parents. parents. W6. Evaluation of AIDS Gene Therapy W6. W6 W6.Evaluation Evaluation ofAIDS AIDS GeneTherapy Therapy strategies by a of group ofGene High School and strategies by a group of High School and strategies by a group of High School and Community College Students in a Science Community ininaaScience CommunityCollege CollegeStudents Students Science enrichment program. (B) enrichment enrichmentprogram. program.(B) (B) Harry Kestler, PhD Harry PhD HarryKestler, Kestler, PhD Professor of Microbiology Professor ofofMicrobiology Professor Microbiology Lorain County Community College Lorain LorainCounty CountyCommunity CommunityCollege College Seven years ago, a scientific learning community was Seven ago, learning community was Sevenyears years ago,aan ascientific scientific learning community was developed around HIV research project. Since then developed around research project. then developed aroundan anHIV HIVstudents researchand project. Since then over 25 undergraduate overSince 20 high over undergraduate and over 20 over 25 25have undergraduate students andare over 20 high high schools participated.students The students looking into schools have participated. The students are looking into schools have participated. The students are looking into the nature of natural mutations of CCR5 a co-receptor the thenature natureofofnatural naturalmutations mutationsofofCCR5 CCR5aaco-receptor co-receptor 7 for for HIV HIV and and mediator mediator of of inflammatory inflammatory signals. signals. The The students students constructed constructed expression expression vectors vectors for for examining examining the the effect effect of of the the alleles. alleles. W7. Laboratory Competency (I) W7 Ruth Natali, MT (ASCP), SH Core Core Lab Lab Operations Operations Manager Manager University University Hospitals Hospitals Case Case Medical Medical Center Center This as a a guide This session session will will serve serve as guide to to fulfilling fulfilling CAP CAP Competency requirements. Competency requirements. We We will will define define the the essential essential elements elements required required to to fulfill fulfill the the CAP CAP competency competency requirements requirements and and discuss discuss ways ways to to design design “test “test systems” systems” that that fit fit your your laboratory’s laboratory’s structure. structure. Specific Specific examples examples of of successful successful methods methods to to document document all all elements elements of of competency competency assessment assessment will will be be shared. shared. W8. How do we get physicians to order the W8 right test? (B) Eugenio H. Zabaleta, PhD Clinical Clinical Chemist Chemist MedCentral MedCentral Health Health System System Healthcare Healthcare reform reform seeks seeks to to make make expenditures expenditures more more efficient efficient and and targeted, targeted, among among other other things. things. Through Through the the implementation implementation of of Information Information Technology Technology (IT) (IT) Health Health Care Care Institutions Institutions have have the the potential potential to to improve improve laboratory laboratory test test utilization, utilization, improve improve patient patient safety, safety, decrease decrease errors errors and and reduce reduce length length of of stay, stay, all all of of which which are are metrics metrics that that can can be be used used in in assessing assessing implementation implementation of of reforms. reforms. W9. Where the data lives: Data W9 Warehousing, Virtualization and “cloud” services in the modern Lab (I) Arkadiy Kheyfets, MS.Eng, PMP, CISSP, CCDA Denise M. O’Conner, MT(ASCP), Six Sigma Black Belt, Lean Healthcare Certified Senior Senior Manager, Manager, Healthcare Healthcare Solutions Solutions Siemens Siemens Healthcare Healthcare Diagnostics, Diagnostics, Inc. Inc. Lean Lean Six Six Sigma Sigma is is becoming becoming a a necessity necessity for for survival survival in in the healthcare industry. Pressure is the healthcare industry. Pressure is constantly constantly increasing increasing to to provide provide the the highest highest quality quality results results in in a a shorter shorter time time frame frame at at the the lowest lowest possible possible cost. cost. Gain Gain an an understanding understanding of of the the fundamentals fundamentals and and tools tools of of Lean Lean Six Six Sigma, Sigma, how how these these tools tools and and principles principles are are used used to to drastically drastically reduce reduce defects, defects, delays delays and and deviation, deviation, and and how how to to sustain sustain improvements improvements once once they they are are implemented. implemented. Sponsored Sponsored by by Siemens Siemens T11 Hemoglobin A1c for the diagnosis of T11. diabetes (B) Sihe Wang, PhD, DABCC, FACB Head, Head, Section Section of of Clinical Clinical Biochemistry Biochemistry Cleveland Clinic Cleveland Clinic Though Though blood blood hemoglobin hemoglobin A1c A1c has has been been accepted accepted as as a a diagnostic diagnostic test test for for diabetes diabetes there there are are issues issues with with this this biomarker biomarker that that both both the the Laboratorians Laboratorians and and clinicians clinicians need need to to be be aware aware of. of. In In this this presentation, presentation, pros pros and and cons cons of of using using HgbA1c HgbA1c for for diagnosis diagnosis of of diabetes diabetes will will be be discussed. discussed. Current Current available available methods methods of of measuring measuring HgbA1c HgbA1c will will also also be be presented. presented. T12 T12. Is the Current Lab Business Model at a Strategic Inflection Point? (B) Khosrow Shotorbani, MBA, MT(ASCP) Vice Vice President, President, Director Director of of Business Business Innovations Innovations ARUP Laboratories ARUP Laboratories Outline Outline of of Information Information Systems Systems layout layout in in the the modern modern mid-range mid-range clinical clinical laboratory. laboratory. Minimizing Minimizing IT IT footprint footprint and and decreasing decreasing cost cost while while increasing increasing systems systems and and services services availability availability due due to to making making smart smart choices. choices. This This presentation will cover which systems to virtualize, presentation will cover which systems to virtualize, which which systems systems and and services services to to move move to to the the cloud cloud and and how how to to make data flow secure and reliable in between. make data flow secure and reliable in between. Coordinating Coordinating primary primary care care services services and and facilitating facilitating collaboration across different providers and collaboration across different providers and organizations organizations are are key key objectives objectives of of patient-centered patient-centered medical medical homes homes and and accountable accountable care care organizations organizations (ACOs) under healthcare reform. Understanding (ACOs) under healthcare reform. Understanding how how these these two two models models redefine redefine the the economic economic value value of of diagnostic diagnostic testing testing where where patient patient care care is is integrated integrated and and value value is is rewarded rewarded over over volume volume helps helps bring bring into into clearer clearer focus focus a a shifting shifting paradigm paradigm for for lab lab organizations, organizations, which which will will result result in in new new industry industry winners winners and and losers. losers. T10. T10 Sponsored Sponsored by by ARUP ARUP Laboratories Laboratories Director Director of of IT IT Cleveland Cleveland HeartLab HeartLab Inc. Inc. Lean Six Sigma: Eliminating the 3 D’s (Delay, Defects, and Deviation) to Produce Better, Faster, More Profitable Results (B) 8 T13. Effective Educational Modalities in T13 Clinical Allied Health Education (B) Craig Clifford, MD, MS Clinical Clinical Medical Medical Assisting Assisting Instructor Instructor Ohio Ohio School School of of Phlebotomy Phlebotomy Prenatal Prenatal Screening Screening has has come come aa long long way way in in 30 30 years. years. From From maternal maternal serum serum alpha alpha fetoprotein fetoprotein (MSAFP) (MSAFP) alone alone for for neural neural tube tube defect defect screening screening only only (NTD), (NTD), the the addition addition of of analytes analytes to to screen screen for for Down Down syndrome syndrome and and now now to to the the use use of of free free fetal fetal DNA DNA in in maternal maternal plasma plasma to to screen screen for for chromosome chromosome abnormalities, abnormalities, the the prenatal prenatal screening screening world world remains remains full full of of choices. choices. The The Ohio Ohio School School of of Phlebotomy’s Phlebotomy’s (OSP) (OSP) clinical clinical medical medical assisting assisting instructor instructor discusses discusses the the problems problems and and solutions solutions to to educational educational differentials differentials in in diverse diverse student student populations. populations. Enlisting Enlisting the the aid aid of of an an early early education education and and development development teacher teacher an an objective objective non-stratified non-stratified paradigm paradigm is is presented presented in in order order to to equally equally engage engage the the students students from from all all educational educational backgrounds. backgrounds. T17 T17. Recurrent infections in an Adult or a T14. KEYNOTE: Working Together: Moving T14 Thomas S. Alexander, PhD, D(ABMLI) from Me to We (B) Nancy J Riesz, MBA, MT(ASCP), ACC President President Success Success Catalyst Catalyst In In today’s today’s world world of of rapid rapid technological technological and and social social change, change, teamwork teamwork is is not not aa luxury. luxury. ItIt is is aa necessity. necessity. Yet, Yet, establishing establishing teamwork teamwork in in the the laboratory laboratory is is not not always always easy. easy. ItIt requires requires commitment, commitment, cooperation cooperation and and effort, effort, as as well well as as aa willingness willingness to to accept accept and and appreciate appreciate the the uniqueness uniqueness of of others. others. This This inter-active inter-active session session shares shares specific specific skills skills and and provides provides solutions solutions for for working working better…. better…. together. together. T15 No, really, what is this patient’s blood T15. type?! (I) Suzanne Bakdash, MD, MPH Staff Staff Physician, Physician, Sections Sections of of Transfusion Transfusion Medicine Medicine and and Hemostasis Hemostasis & & Thrombosis Thrombosis Cleveland Cleveland Clinic Clinic ABO ABO blood blood types types are are determined determined by by identifying identifying and and comparing comparing ABO ABO antigens antigens on on aa patient’s patient’s red red blood blood cells cells (forward (forward typing) typing) with with antibodies antibodies in in their their plasma plasma (reverse (reverse typing). typing). Blood Blood type type discrepancies discrepancies arise arise when when the the forward forward and and reverse reverse types types don’t don’t match! match! This This presentation presentation will will review review the the fundamentals fundamentals of of ABO ABO blood blood type type determination determination and and discuss discuss case case examples examples of of ABO ABO typing typing discrepancies. discrepancies. T16. Prenatal Screening 101 (B) T16 Christine Wensel, MS, CGC Genetic Genetic Counselor Counselor University University Hospitals Hospitals Case Case Medical Medical Center Center –– Center Center for for Human Human Genetics Genetics Laboratory Laboratory Kid? It might be a PID! Clinical and Laboratory Update on Primary Immune Deficiencies (I) Immunologist Immunologist Summa Summa Health Health System System Over Over 150 150 primary primary immune immune deficiencies deficiencies (PID) (PID) have have been been described. described. These These diseases diseases are are associated associated with with diagnostic diagnostic dilemmas dilemmas and and confusing confusing board board questions. questions. This This talk talk describes describes the the major major classes classes of of PIDs, PIDs, the the more more common common PIDs, PIDs, and and presents presents diagnostic diagnostic algorithms, algorithms, including including newer newer molecular molecular assays. assays. Clinical Clinical case case presentations presentations will will be be used used to to highlight highlight specific specific diseases. diseases. T18 Pediatric Blood Sparing: An T18. interdisciplinary quality improvement initiative to standardize and minimize blood sampling volumes and reduce preanalytical testing errors. (I) Paula L. Forsythe, MSN, RN, CNS Clinical Clinical Nurse Nurse Specialist Specialist for for Neonatal Neonatal Services Services Rainbow Rainbow Babies Babies and and Children’s Children’s Hospital, Hospital, University University Hospitals Hospitals Case Case Medical Medical Center Center Pediatric Pediatric Blood Blood Sample Sample Guidelines Guidelines were were standardized standardized for for more more than than 50 50 of of the the most most frequent/essential frequent/essential pediatric pediatric blood blood tests, tests, including including blood blood bank bank specimens. specimens. Guidelines Guidelines include include appropriate appropriate tube tube selection selection and and special special handling handling requirements. requirements. This This interdisciplinary, interdisciplinary, problem-solving problem-solving approach approach resulted resulted in in improvement improvement in in the the quality quality and and safety safety of of specimen specimen collection, collection, improved improved communication communication between between disciplines, disciplines, and and reduced reduced pre-analytical pre-analytical test test errors. errors. 9 T19 T19. Leadership in an emerging healthcare organization (B) Jake Orville CEO Cleveland HeartLab, Inc. How to engage and make an emotional connection with employees in a high growth, high paced environment. T20. You Say Apple, I say Orange, An T20 Attempt to Standardize the Grading of Hematology Morphology (I) Catherine Shaffner, MLS(ASCP)CMSH Education Coordinator ProMedica Ideally, within a laboratory, standardized definitions and reporting format should be employed – but are they? How do you even attempt to ensure everyone calls an apple an apple? All major aspects of red cell morphology are reviewed in this richly illustrated interactive course that uses numerous photomicrographs to identify and heighten study of morphologic abnormalities in red cell size, shape, and color. This course is ideal for review by techs and students and use in continuing education and cross training. T21 T21. Health Care Reform Status Report – 3 years since PPACA signed into law (I) Paul Labbe, Masters in Clinical Laboratory Technology (MCLT) V.P. Hospital Solutions CompuNet Clinical Laboratories Discussion/debate of the Patient Protection and Affordable Care Act (PPACA) and the changes and impact to the initial reform proposals along with the deletions, revisions to be expected from such a comprehensive package of reforms. The PPACA was signed into law on March 23, 2010 and the US Supreme Court upheld the constitutionality of most of the PPACA on June 28, 2012. Review of what is in place and what is still planned for implementation will be presented. T22. T22 Moving on Up! Fast Track & Career Paths for Phlebotomists (I) Elaine Ewald VP Specimen Collection & Processing CompuNet Clinical Laboratories 10 Terrie McManes Director Patient Services CompuNet Clinical Laboratories This program will outline the use of Career Path and Fast Track to reward phlebotomists for achieving increasing skills levels and experience in both inpatient and outpatient setting. Sponsored by CompuNet Clinical Laboratories T23. How Reproductive Laboratories Differ T23 from Clinical Laboratories (I) Doris J. Baker, PhD, MT (ASCP), HCLD (ABB), Emb-Acad. (ACE) Professor University of Kentucky Discussion of the differences and similarities between reproductive laboratories and clinical laboratories. Topics include the andrology and embryology procedures performed, such as semen analysis, in vitro fertilization, gamete and embryo cryopreservation, numbers of each facility type, specific personnel requirements, and the regulatory/certification agencies involved. T24. T24 Pediatric Phlebotomy (I) Randy Gruhlke BS, CPT, (NHA) Associate Program Director – Phlebotomy Program, Mayo School of Health Sciences Education Specialist – Clinical Core Laboratory Services Mayo Clinic This presentation will reveal the intricacies related to pediatric phlebotomy; included in the discussion, the relevance and effectiveness of communication with the pediatric patient, the role the parents play in pediatric phlebotomy, collection equipment choices, techniques, restraints and specimen concerns including collection volumes and the value of a dedicated pediatric phlebotomy staff. Sponsored by Mayo Medical Laboratories T25 T25. Are These Lab Values Accurate? Evaluating Laboratory Results with Specimen Quality (I) Sandra VanVranken, MS, MT(ASCP)SH Laboratories Laboratories Compliance Compliance Manager Manager The The Ohio Ohio State State University University Wexner Wexner Medical Medical University University Center Center This This presentation presentation reviews reviews aa variety variety of of pre-analytical pre-analytical conditions conditions that that can can lead lead to to inaccurate inaccurate laboratory laboratory results. results. The The participants participants will will discuss discuss how how problems problems with with specimen specimen quality quality directly directly correlate correlate to to extreme extreme laboratory laboratory results. results. Many Many case case studies studies in in specimen specimen quality quality will will be be discussed, discussed, along along with with typical typical laboratory laboratory results results that that are are produced. produced. Examples Examples include; include; IV IV contaminated contaminated specimens, specimens, hemolyzed hemolyzed specimens, specimens, clotted clotted specimens, specimens, improper improper temperatures temperatures for for storage, storage, effect effect of of anticoagulation, anticoagulation, etc. etc. T26. A tale of two algorithms: Laboratory T26 diagnosis of HIV and Treponema pallidum infection. (I) Mario J Marcon, PhD, D(ABMM), Director, Director, Clinical/Molecular Clinical/Molecular Microbiology, Microbiology, Virology, Virology, Immunoserology Immunoserology Labs Labs Nationwide Nationwide Children's Children's Hospital Hospital Clinical Clinical Professor Professor of of Pediatrics Pediatrics and and Pathology Pathology Ohio Ohio State State University University College College of of Medicine Medicine Laboratory Laboratory diagnosis diagnosis of of HIV HIV and and Treponema Treponema pallidum pallidum infections infections have have traditionally traditionally relied relied on on serologic serologic “screening” “screening” assays assays followed followed by by supplemental supplemental serologic serologic tests tests to to establish establish the the diagnosis. diagnosis. Such Such traditional traditional “2-step” “2-step” algorithms algorithms generally generally call call for for performing performing aa less less complex complex test test first first followed followed by by aa more more technologically technologically complex complex test test ifif the the initial initial test test is is positive. positive. Such Such an an approach approach often often leads leads to to delays delays in in reporting reporting of of final final test test results results and and thus thus may may negatively negatively impact impact patient patient care. care. Recent Recent studies studies have have supported supported the the use use of of 4th 4th generation generation antibody/antigen antibody/antigen screening screening EIAs EIAs coupled coupled with with alternative alternative serologic serologic tests tests to to replace replace Western Western blot blot for for confirming confirming HIV HIV infection, infection, as as well well as as the the use use of of nucleic nucleic acid acid amplification amplification diagnostic diagnostic tests. tests. Similarly, Similarly, aa so-called so-called “reverse “reverse algorithm” algorithm” for for T. T. pallidum pallidum infection, infection, whereby whereby aa treponemal treponemal test test is is performed performed first first to to be be followed followed by by aa nontreponelal nontreponelal test test ifif positive, positive, has has been been studied studied for for the the serologic serologic diagnosis diagnosis of of syphilis. syphilis. This This presentation presentation will will provide provide an an update update to to available available current current guidelines guidelines for for diagnosis diagnosis of of HIV HIV and and T. T. pallidum pallidum infection. infection. T27. T27 What Next? I want or need a new job! (B) James A. Rowe, MBA, HT, MT (ASCP), FACHE Operations Operations Manager Manager AmeriPath AmeriPath (A (A Division Division of of Quest) Quest) Tips Tips and and experiences experiences on on the the job job search, search, the the telephone telephone interview, interview, and and even even some some thoughts thoughts on on what what to to think think about about ifif you you are are placed placed on on corrective corrective action action or or let let go go from from your your job. job. T28. T28 Critical Values: Cutoffs, Communication, and Impact on Care (B) Christine Schmotzer, MD Director Director of of Clinical Clinical Chemistry Chemistry University University Hospitals Hospitals Case Case Medical Medical Center Center Critical Critical value value communication communication is is aa key key focus focus of of The The Joint Joint Commission Commission National National Patient Patient Safety Safety Goals. Goals. This This session session will will cover cover common common critical critical values values challenges challenges including including identification identification of of resources resources for for determining determining critical critical value value cutoffs; cutoffs; comparison comparison of of models models for for communication communication and and documentation documentation of of critical critical results results (call (call centers, centers, automated automated notification notification systems, systems, or or bench bench technologists); technologists); and and current current recommendations recommendations on on benchmark benchmark notification notification times times and and repeating repeating critical critical tests tests results. results. T29. T29 Laboratory Monitoring of Heparin Therapy (I) Kathy Shingler, MT(ASCP) Clinical Clinical Hemostasis Hemostasis Specialist Specialist Instrumentation Instrumentation Laboratory Laboratory This This session session will will discuss discuss heparin heparin anticoagulant anticoagulant therapy therapy and and the the challenges challenges the the laboratory laboratory faces faces in in determining determining aa true true therapeutic therapeutic range range and and meeting meeting guidelines. guidelines. Various Various methods methods for for establishing establishing aa range range are are discussed discussed as as well well as as the the value value for for monitoring monitoring heparin heparin using using Anti-Xa. Anti-Xa. Monitoring Monitoring with with Anti-Xa Anti-Xa has has been been shown shown that that patients patients are are within within therapeutic therapeutic range range faster faster than than monitoring monitoring with with APTT. APTT. Discussion Discussion will will take take place place as as to to how how your your lab lab can can transition transition to to this this method method of of heparin heparin monitoring. monitoring. Sponsored Sponsored by by Instrumentation Instrumentation Laboratory Laboratory 11 F30 Reviewing and Revising Reference F30. Intervals: Challenges and Options (B) Amy L. Pyle, PhD, DABCC Assistant Director of Core Laboratory Nationwide Children's Hospital Establishing and renewing reference intervals can be a challenge to laboratorians, so that many just blindly use existing or published ranges. There’s a better way, though, and it can be accomplished without too much work. This talk will review the principles of establishing, verifying, and transferring reference intervals. F31. Rapid Identification of Blood Culture F31 Isolates (I) Ike Northern, MT, M (ASCP), MS Microbiology Director of Infectious Disease Testing CompuNet Clinical Laboratories Rapid identification of blood culture isolates can have a major impact on patient care, patient outcome, and length of hospital stay. There are numerous options for performing rapid identification on these isolates. This talk will discuss these options, taking into consideration the sensitivity, ease of use, and cost. F32 Metabolic Acidosis & Metabolic F32. Alkalosis (I) Michael D. Patterson, DO Vice President, Chief Medical Officer MedCentral Health System Although buffers in the body fluids help resist changes in the pH of body fluids, the respiratory system and the kidneys regulate the pH of the body fluids. Malfunctions of either the respiratory system or the kidneys can result in acidosis or alkalosis with life threatening consequences. This talk will explore the causes and effects of metabolic acidosis and alkalosis, as well as the body's compensation mechanisms F33 Clotting or Bleeding? A Case StudyF33. Based Review of Hemostasis (I) Charity Accurso, PhD MT(ASCP) Interim Program Director, Medical Laboratory Science Program University of Cincinnati 12 This session will be a case study-based review of Hemostasis. Through the review of a series of case studies, we will review normal and abnormal physiology of hemostasis, as well as the diagnostic strategies for diagnosis. F34 ASCP Board of Certification F34. Examinations and Certification Maintenance Program (I) Susan L. Wilkinson, EdD, MT(ASCP)SBBCM Interim Department Head, Analytical and Diagnostic Sciences, College of Allied Health Sciences, and Associate Professor Emerita University of Cincinnati The ASCP Board of Certification criterion-referenced examination model and the computer adaptive testing strategy will be reviewed. Statistics for the MLT, MLS and DLM examinations will be reviewed over a 10-year period. These statistics will include: numbers of individuals who took the exam, percentages of those who successfully achieved certification, and the percentage of NAACLS 1st time test takers who successfully achieved certification. Various routes to take the MLT, MLS and DLM examinations will be reviewed and the Certification Maintenance Program will be described. F35 F35. Controlling Genetic Test Send Out Volume (I) Patty Taneja, MS, CGC Supervisor Center for Human Genetics Laboratory - University Hospitals of Cleveland Genetic testing is more available and more affordable than ever. No lab offers a comprehensive test menu, thus sending samples to other laboratories is a common practice. Paired with increasing issues with insurance coverage, a tug of war exists between appropriate ordering and resource allocation. This talk highlights the practices put into place to address this, and the lessons learned. F36 Trauma Packs & Massive F36. Transfusions, What to Do? (I) Suzanne H. Butch, MA, MLS(ASCP)CM, SBBCM Administrative Manager, Blood Bank & Transfusion Service and Compliance Manager University of Michigan Hospitals & Health Centers This session will review the benefits and challenges associated with protocols for trauma packs and massive transfusions both large and This sessionforwill review the smaller benefitsinstitutions. and challenges associated with protocols for trauma packs and massive transfusions both large and smaller institutions. F37. BloodforGases – Let’s Get Clinical (I) Erik Gallion, RCP/RRT F37 F37. Blood Gases – Let’s Get Clinical (I) Manager Cardiac/Vascular and Pulmonary Services MedCentral Health System Erik Gallion, RCP/RRT Manager Cardiac/Vascular and Pulmonary Services Normal blood pH must be maintained within a narrow MedCentral Health System range of 7.35-7.45 to ensure the proper functioning of metabolic processes andbe themaintained delivery of the right Normal blood pH must within a amount narrow of oxygen to tissues. This talk review acid-base range of 7.35-7.45 to ensure the will proper functioning of disorders due to lungand diseases or conditions that affect metabolic processes the delivery of the right amount normal breathing, andThis cause in acid-base the CO2 of oxygen to tissues. talk changes will review concentration. disorders due to lung diseases or conditions that affect normal breathing, and cause changes in the CO2 concentration. F38. Drug Screening for Pain Management M. S. Stegall & Associates, LLC In this era of&Accountable Care, Hospital providers will M. S. Stegall Associates, LLC be facing significant revenue shrinkage from all payers. As this revenue up, so does funding for new In era ofdries Accountable Care,internal Hospital providers will capital initiatives. Internal competition for scarce capital be facing significant revenue shrinkage from all payers. dollars will be fierce. session will teach youfor how to As revenue dries up,This so does internal funding new developinitiatives. compellingInternal business cases andforpresent to capital competition scarcethem capital senior leadership to obtain requiredwill funding. dollars will be fierce. This session teach you how to develop compelling business cases and present them to senior leadership required funding. F41. A review to ofobtain antimicrobial susceptibility F41 testing methods (I) F41. A review of antimicrobial susceptibility Joel Mortensen, MLT (AMT), PhD testing methods (I) Director, Diagnostic Infectious Diseases Testing Laboratories Joel Mortensen, MLT (AMT), PhD University Hospitals Departments Case Medical of Center Senior Instructor, Anesthesiology & Psychiatry Review of Hospitals clinical indications and Center current guidelines for University Case Medical when a Urine Drug Screen would be indicated in a patient. of A review risk stratification and guidelines frequency for of Review clinical of indications and current screening will be presented. when a Urine Drug Screen would be indicated in a patient. A review of risk stratification and frequency of screening will be presented. F39. Molecular Genetics of Cincinnati Children's Director, DiagnosticHospital Infectious Diseases Testing Professor, Department of Pathology and Laboratory Laboratories Medicine Children's Hospital Cincinnati University ofDepartment Cincinnati of Pathology and Laboratory Professor, Medicine One area of microbiology has more impact on the University of clinical Cincinnati care of our patients, yet may get the least attention. In the era antibiotics more antibiotic One areaofof fewer clinical new microbiology hasand more impact on the resistance, every medical technologist needs to care of our patients, yet may get the least attention. In understand the basics of the methods used today. Each the era of fewer new antibiotics and more antibiotic method or every systemmedical has itstechnologist own strengths resistance, needs and to weaknessesthe - which is the right one? This session understand basicsone of the methods used today. Each will review methods results in and this method or the system hasanditskinds own of strengths critical area of- microbiology. weaknesses which one is the right one? This session will review the methods and kinds of results in this Sponsored bymicrobiology. Meridian Bioscience critical area of F39 F39. Molecular Genetics of Myelodysplastic – New Discoveries Explain Sponsored by Meridian F42. Laboratories inBioscience Developing Countries: F42 Therapeutic Sciences PhD, MLS J. Lynne Williams, Pathology B. LaurelDepartment, Elder, PhDBoonshoft School of Medicine, (I) F38 F38. Drug Screening for Pain Management Binit J. Shah, MD (I) Senior Instructor, Departments of Anesthesiology & Psychiatry Binit J. Shah, MD Myeloproliferative Neoplasms and Myeloproliferative Neoplasms and Old Observations (I) Myelodysplastic – New Discoveries Explain J. Lynne Williams, PhD, MLS Old Observations (I) Professor & Program Director, Biomedical Diagnostic & Oakland University Professor & Program Director, Biomedical Diagnostic & Therapeutic Sciences ImprovedUniversity molecular analyses over the past several Oakland years have resulted in the identification of new genes involved molecular in myelodysplastic and Improved analyses over syndromes the past several myeloproliferative neoplasms. A better understanding of years have resulted in the identification of new genes the molecular basis of these disorders is resulting in new involved in myelodysplastic syndromes and therapeutic approaches. myeloproliferative neoplasms. A better understanding of the molecular basis of these disorders is resulting in new therapeutic approaches. F40. Develop a Business Case That Will Get Your Initiative Funded (I) F40 F40. Develop a Business Case That Will Get M. Susan Stegall, Certified Management Your Initiative Funded (I) Consultant, MBA, MHSA, MT(ASCP) Owner & CEO Stegall, Certified Management M. Susan Consultant, MBA, MHSA, MT(ASCP) Owner & CEO M. S. Stegall & Associates, LLC In this era of Accountable Care, Hospital providers will be facing significant revenue shrinkage from all payers. As revenue dries up, so does internal funding for new capital initiatives. Internal competition for scarce capital dollars will be fierce. This session will teach you how to develop compelling business cases and present them to senior leadership to obtain required funding. A Cambodian Experience (B) F42. Laboratories in Developing Countries: B. Laurel Elder, PhD A Cambodian Experience (B) Associate Professor Wright State University Associate Professor Pathology Department, Boonshoft School of Medicine, Cambodia faced tremendous challenges, including Wright Statehas University genocide and civil unrest, as it strives to develop a health carehas infrastructure. Laboratories in Cambodia are Cambodia faced tremendous challenges, including just now beginning to develop facilities that will genocide and civil unrest, as it into strives to develop a supportcare patient care. Laboratories This talk will share one health infrastructure. in Cambodia are microbiologist’s three-month experience helpingthat to train just now beginning to develop into facilities will microbiologists in Cambodia as a volunteer with the support patient care. This talk will share one Diagnostic Microbiology Development Program. microbiologist’s three-month experience helping to train microbiologists in Cambodia as a volunteer with the Diagnostic Microbiology Program. (I) F43. Vaccination IsDevelopment Not Immunization F43 Kathy V. Waller, PhD, MLS(ASCP) F43. Vaccination Is Not Immunization (I) Associate Professor The OhioV.State University Kathy Waller, PhD, MLS(ASCP) Associate Professor Whether or not to vaccinate one’s child is a critical decision a parent must make. Newborns and babies have not yet developed the neurological system, yet may be subjected to 22 vaccines by 6 months of age and 68 total vaccines by 12 years. In this session, participants will discuss the risks and benefits of vaccines. 13 F44. What to do with the new technology and molecular methods in clinical The Ohio State University The Ohio or State Whether notUniversity to vaccinate one’s child is a critical decision a parent must make. Newborns and babies have not yet the neurological system, may Whether or developed not to vaccinate one’s child is ayetcritical be subjected to 22 vaccines by 6 Newborns months of age 68 decision a parent must make. and and babies total by 12 years. In this session, participants havevaccines not yet developed the neurological system, yet may will discuss thetorisks and benefits vaccines. be subjected 22 vaccines by 6ofmonths of age and 68 total vaccines by 12 years. In this session, participants will discuss and benefits of vaccines. F44. Whatthe torisks do with the new technology F44 and molecular methods in clinical F44. What to do(I) with the new technology microbiology?! and molecular methods in clinical Joel Mortensen, (I) MLT (AMT), PhD microbiology?! Director, Diagnostic Infectious Diseases Testing Laboratories Joel Mortensen, MLT (AMT), PhD Cincinnati Hospital Director, Children's Diagnostic Infectious Diseases Testing Professor, LaboratoriesDepartment of Pathology and Laboratory Medicine Cincinnati Children's Hospital University Cincinnati of Pathology and Laboratory Professor,ofDepartment Medicine University Cincinnati We are onofthe cusp of the biggest change in clinical microbiology since Louis Pasteur declared that life did not spontaneously! There are more technologies We arise are on the cusp of the biggest change in clinical and methodologies down the microbethat road microbiology since coming Louis Pasteur declared lifethan did at time before.......but There which ones will add value to notany arise spontaneously! are more technologies the of patients and which onesthe canmicrobe we afford? andcare methodologies coming down road than at any time before.......but which ones will add value to Sponsored by Meridian Bioscience the care of patients and which ones can we afford? Sponsored by Meridian F45. Leukemia CaseBioscience Studies: the Good, the F45 Bad and the Ugly (I) F45. Leukemia Case Studies: the Good, the Roslyn McQueen, PhD, CCRC Bad and the Ugly (I) Certified Clinical Research Coordinator Hurley Medical Center PhD, CCRC Roslyn McQueen, Certified Clinical Research Coordinator Medical Center cases will be introduced and AHurley number of leukemia discussed as to 1) morphologic presentation 2) laboratory and 3) final diagnosis. discussion A numberdata of leukemia cases will beOpen introduced and is encouraged. discussed as to 1) morphologic presentation 2) laboratory data and 3) final diagnosis. Open discussion is encouraged. F46 F46. iPath touch: The Value of Touch Imprints in Pathology (I) F46. iPath touch: The Value of Touch Samir B. Kahwash, MD (I) Imprints in Pathology Vice Chair for Education, Department of Pathology Nationwide Hospital Samir B. Children’s Kahwash, MD Vice Chair for Education, Department of Pathology Nationwide Children’s Hospital This presentation will focus on the value and utilization of touch imprint interpretation in Clinical and Surgical Pathology. This presentation will focus on the value and utilization of touch imprint interpretation in Clinical and Surgical Pathology. 14 F47. Project Management Made Easy plus Fundamentals (B) F47 Project Management Made Easy plus F47. M. Susan Stegall, Fundamentals (B) Certified Management Consultant, MBA, MHSA, MT(ASCP) M. Susan Owner & CEO Stegall, Certified Management M. S. Stegall & Associates, LLC MT(ASCP) Consultant, MBA, MHSA, Owner & CEO M. S. Stegall & Associates, LLC day of delay is costly. When managing a project, every Issues become barriers to implementations. Scope expansion delaysa project, implementation destroys a When managing every day and of delay is costly. project's return barriers on investment. Effective project Issues become to implementations. Scope management supports your organization enablesa expansion delays implementation and and destroys the people return within toonorchestrate a multitude of initiatives project's investment. Effective project in a professional andyour realistic manner. Project management supports organization and enables management, when done right, enables ofprogress-the people within to orchestrate a multitude initiatives responsibility, accountability, and success. in a professional and realistic manner. Project management, when done right, enables progress-responsibility, accountability, and success. F48. Interferon Gamma Release Assays (IGRAs) in the Diagnosis of Tuberculosis (I) F48. Interferon Gamma Release Assays F48 Richard PhD, D(ABMM) (IGRAs) B. in Clark, the Diagnosis of Tuberculosis (I) Scientific Director of Microbiology/Virology Quest Diagnostics Nichols Institute, Chantilly Richard B. Clark, PhD, D(ABMM) Scientific Director of Microbiology/Virology Questpresentation Diagnostics Nichols Institute, This will review the Chantilly role of Interferon Gamma Release Assays (IGRAs) in detecting both latent and clinical will disease This presentation reviewdue the toroleMycobacterium of Interferon tuberculosis. Included will (IGRAs) be a discussion as to both the Gamma Release Assays in detecting sensitivity specificity of these (Quantiferon latent andandclinical disease due assays to Mycobacterium and T-Spot)Included in detecting TB infections. tuberculosis. will be a discussion as to the Recommendations as to when to use the IGRAs will be sensitivity and specificity of these assays (Quantiferon discussed. and T-Spot) in detecting TB infections. Recommendations as to when to use the IGRAs will be Sponsored discussed. by Quest Diagnostics Sponsored Quest Diagnostics F49. BloodbyProduct utilization & Wastage (B) F49 Blood Product utilization & Wastage F49. Bob (B) Reigle, MLS (ASCP) Transfusion Services Supervisor MedCentral Health System - Mansfield Hospital Bob Reigle, MLS (ASCP) Transfusion Services Supervisor MedCentral Health System - Mansfield Hospital Transfusion of blood products, including whole blood, red blood cells, platelets, plasma and cryoprecipitate, is an essential of part of patient care. Although thereblood, are Transfusion blood products, including whole many clinical blood product red blood cells,practice platelets,guidelines plasma andforcryoprecipitate, is usage, the lack strong evidence supportingthere specific an essential partof of patient care. Although are practices often leads to overuse of blood With many clinical practice guidelines for products. blood product millions of blood products each yearspecific in the usage, the lack of strong transfused evidence supporting United improving utilization and decreased practicesStates, often leads to overuse of blood products. With wastage it isblood a critical aspecttransfused of transfusion medicine. millions of products each year in the United States, improving utilization and decreased wastage it is a critical aspect of transfusion medicine. Ohio Laboratory Collaborative 2012 Ohio Clinical Laboratory Collaborative 2013 OhioClinical Clinical Laboratory Collaborative 20132012 Organizations Sponsoring Sponsoring Organizations Sponsoring Organizations American Association of Clinical Chemistry (AACC) American Association of Clinical Chemistry (AACC) American Association of Clinical Chemistry (AACC) North Eastern Ohio AACC North Eastern Ohio AACCLeadership Leadership North Eastern Ohio Leadership AACC Eugenio Zabaleta, PhD, Chair Eugenio Zabaleta, PhD, PhD, ChairChair Eugenio Zabaleta, MedCentral Health System MedCentral HealthSystem System -MedCentral Health ChristineChristine Schmotzer, MD, Chair Elect Christine Schmotzer, MD, Chair Elect Schmotzer, MD, Chair Elect UH-UH Case Medical Center UH Medical Case Medical Center Case Center Sihe Wang, PhD,Delegate Delegate Lisa Kubit, Past Chair, Lisa Kubit, Past Chair, Program ChairProgram Sihe Wang, PhD, Delegate Lisa Kubit, Past Chair, Program ChairChair Sihe Wang, PhD, -Cleveland ClinicClinic -Cleveland HeartLab, Inc. Cleveland HeartLab, Inc. Cleveland Clinic Cleveland HeartLab, Inc. Cleveland David Anderson, PhD, Treasurer Dustin Bunch, Continuing David Anderson, PhD, Treasurer David Anderson, PhD, Treasurer -Cleveland State University Education/Website Coordinator ClevelandCleveland State University State University -Cleveland Clinic Anne Bordner Blank, Secretary Dustin Bunch, Continuing Education/Website Coordinator Dustin Bunch, Continuing Education/Website Coordinator -Cleveland Clinic ClevelandCleveland Clinic Clinic With nearly 10,000 members, AACC is the largest international society of With nearly 10,000 AACC laboratory is AACC the largest society ofsociety research With nearlymembers, 10,000 isprofessionals, theinternational largest international of research research orientedmembers, clinical physicians, research oriented clinical laboratory professionals, physicians, research scientists and others oriented clinical professionals, physicians, research scientists and others scientists andlaboratory others in the field of clinical laboratory medicine. Founded in 1948, in the field of clinical laboratory medicine. Founded in 1948, the society is in the the society field ofis headquartered clinical laboratory medicine. DC. Founded 1948, come the society in Washington, AACC in members from a is headquartered in of Washington, DC. AACC members come industry from a(26%) variety headquartered in Washington, DC. AACC come from a of variety of variety employment settings: hospital labsmembers (50%), and employment settings: settings: hospital labs 30% (50%), industry (26%) is and independent employment hospital labs (50%), industry (26%) and independent independent labs (24%). of the membership international. 23 labs local arealabs (24%). 30% of the membership is international. area sections and 13 and 13 (24%). 30%and of 13 thespecialty membership is international. 23 local area sections sections divisions focus23 onlocal laboratory medicine subspecialties specialty specialty divisions focus onfocus laboratory medicine subspecialties such asDiagnostics, Point as of Point on laboratory medicine subspecialties such such asdivisions Point of Care, Pediatric Maternal Fetal, and Molecular to of Care, Pediatric Maternal Fetal, andFetal, Molecular Diagnostics, to name atofew. Care, Pediatric and Molecular Diagnostics, name a few. name a few. Maternal AACC’s annual meeting and exposition isexposition often held with ASCLS and is theandand AACC’s annual meeting andand exposition is often held jointly withwith ASCLS is the AACC’s annual meeting isjointly often held jointly ASCLS is largest inlargest thethe field medicine attracting nearlyattracting 20,000 andparticipants in of thelaboratory field of field laboratory medicine attracting nearlyparticipants 20,000 participants and largest in the of laboratory medicine nearly 20,000 600 exhibitors. AACC is AACC a majorisAACC publisher of books and fiveofmajor periodicals on 600and exhibitors. a major of books and five major on 600 exhibitors. is apublisher major publisher books and fiveperiodicals major clinical laboratory science. Clinical Chemistry is an international peer reviewed clinical laboratory science. Clinical Chemistry is an international reviewed periodicals on clinical laboratory science. Clinical Chemistry ispeer an international journal and is theand most cited journal injournal the field. Clinical Laboratory offers journal is the most cited in the field.journal Clinical News offers peer reviewed journal and is the most cited in Laboratory theNews field. Clinical breaking breaking news stories feature and viewpoints from newswith stories witharticles feature articles and viewpoints fromclinical leading and clinical Laboratory News offers breaking news stories withleading feature articles laboratorylaboratory scientists. Clinical Laboratory Strategies addresses the essentials of scientists. Clinical Laboratory Strategies addresses the essentials viewpoints from leading clinical laboratory scientists. Clinical Laboratory of laboratorylaboratory management and mastering change inchange laboratory practice. In addition to management and in laboratory practice. Inmastering addition to Strategies addresses themastering essentials of laboratory management and the AACCthe member a joint venture ASCLS, Lab TestsLab Online AACC website, member website, a jointInwith venture with ASCLS, Testswebsite, Online a joint change in laboratory practice. addition to the AACC member (www.labtestsonline.org) has won several awards and hostsand more than 700,000 (www.labtestsonline.org) wonOnline several awards hosts more than venture with ASCLS, Labhas Tests (www.labtestsonline.org) has 700,000 won visitors per month. information on AACC visit www.aacc.org. visitors perFor month. For information AACC visit visitors www.aacc.org. several awards and hosts more on than 700,000 per month. For information on AACC visit www.aacc.org. Northeast Ohio AACC Leadership can be found at: http://www.aacc.org/members/committees/local_section/Pages/LSNEO.aspx 15 2013 Ohio Clinical Laboratory Collaborative Ohio Clinical Laboratory Collaborative 2012 2012 Sponsoring Organizations Sponsoring Organizations American Society for Clinical Laboratory Science – Ohio (ASCLS-Ohio) American Association of Clinical Chemistry (AACC) American Association of Clinical Chemistry (AACC) North Eastern Ohio Leadership AACC Leadership North Eastern Ohio AACC Eugenio Zabaleta, PhD, Chair Eugenio Zabaleta, PhD, Chair MedCentral Health System ASCLSOhio Leadership MedCentral Health System Schmotzer, MD, Chair Elect ChristineChristine Schmotzer, MD, Chair Elect UH CaseCenter Medical Center UH Case Medical Stacy Baker, Interim President Melanie Giusti, Senior Director Lisa Kubit, Past Chair, Program Chair Sihe Wang, Sihe Wang, PhD, Delegate Lisa Kubit, Past Chair, Program PhD, Delegate -Galloway, Ohio Chair -Florence, Kentucky Cleveland HeartLab, Inc. Cleveland Clinic Cleveland HeartLab, Inc. Cleveland Clinic Shannon Kern, Recording Secretary Greg Attenweiler, Senior Director -Proctorville, Ohio -Dayton, Ohio David Anderson, PhD, Treasurer David Anderson, PhD, Treasurer Catherine Shaffner, Treasurer Sheila Ng, Junior Director Cleveland State University Cleveland State University -Perrysburg, Ohio -Toledo, Ohio Laura Hook, Senior Director Linda Graeter, Junior Director DustinContinuing Bunch, Continuing Education/Website Coordinator Dustin Bunch, Education/Website Coordinator -Canal Winchester, Ohio -Waynesville, Ohio ClevelandCleveland Clinic Clinic With10,000 nearlymembers, 10,000 members, AACC is theinternational largest international of research With nearly largest society ofsociety research Founded in 1933,AACC ASCLSisisthe made up of and governed by practitioners in clinical clinical laboratory professionals, physicians, research scientists and others oriented oriented clinical laboratory professionals, physicians, research scientists and others laboratory science. ASCLS-OH’s mission is to promote the profession of clinical in the of laboratory clinical laboratory medicine. Founded inthe 1948, the is society is in the field of field clinical medicine. Founded in 1948, society laboratory science in Ohio and provide beneficial services to those who practice headquartered in Washington, DC. members AACC members comea from a of variety of headquartered in Washington, DC. AACC come from variety it. employment settings: hospital labs (50%), industry (26%) and independent labs employment settings: hospital labs (50%), industry (26%) and independent labs (24%). of the membership is international. local area sections (24%). 30% of 30% the membership is international. 23 local 23 area sections and 13 and 13 specialty divisions focus on laboratory medicine subspecialties such as specialty divisions focus on on laboratory medicine subspecialties as Point of Point of Besides serving the board of directors, committeessuch or scientific assemblies for Care,ASCLS-OH, Pediatric Fetal, tofew. name a few. Care, Pediatric MaternalMaternal Fetal, and Molecular Diagnostics, to name a members mayand alsoMolecular choose toDiagnostics, work with ASCLS national committees. ASCLS publishes a bimonthly journal, Clinical Laboratory AACC’s annual and meeting and exposition is often held jointly withand ASCLS AACC’s annual meeting exposition is often held jointly with ASCLS is theand is the along a monthly national newsletter, ASCLS in of thelaboratory field of with laboratory medicine attracting nearly 20,000Today. participants and largest inlargest the Science, field medicine attracting nearly 20,000 participants andASCLS-OH publishes a newsletter, Ohio CLS Today. 600 exhibitors. a major publisher books and five major periodicals on 600 exhibitors. AACC is AACC a majorispublisher of books of and five major periodicals on clinical laboratory Clinical Chemistry is an international peer reviewed clinical laboratory science. science. Clinical Chemistry is an international peer reviewed journal is the most citedinjournal in the field. Laboratory Clinical Laboratory News offers journal and is theand most cited journal the field. Clinical News offers laboratorians are toand be viewpoints members offrom ASCLS e.g.clinical clinical newswith stories withinvited feature articles and viewpoints from leading laboratory clinical breaking breaking newsAllstories feature articles leading scientists, clinical laboratory technicians, histotechnologists, histotechnicians, laboratory scientists. Clinical Laboratory Strategies addresses the essentials of laboratory scientists. Clinical Laboratory Strategies addresses the essentials of generalists, specialists, managers/supervisors, phlebotomists and others. Please laboratory management and mastering in laboratory In to addition to laboratory management and mastering change inchange laboratory practice. practice. In addition join us at the ASCLS-OH Membership Booth to learn more about ASCLS and the AACC member website, a joint venture with ASCLS, Lab Tests Online the AACC member website, a joint venture with ASCLS, Lab Tests Online ASCLS-OH or visit our websiteswww.ascls.org and www.ascls-ohio.org. (www.labtestsonline.org) wonawards severaland awards hosts more than 700,000 (www.labtestsonline.org) has won has several hostsand more than 700,000 visitors perFor month. For information AACC visit www.aacc.org. visitors per month. information on AACCon visit www.aacc.org. All ASCLS members including students are encouraged to join the ASCLS-Ohio leadership during the conference at the Board of Directors meeting (which will be held on Wednesday May 8th at 7pm) and the .Member Business Meeting (which will be held on Friday May 10th at 7:30am). 16 2013 Ohio Clinical Laboratory Collaborative Ohio Clinical Laboratory Collaborative 2012 2012 Sponsoring Organizations Sponsoring Organizations Clinical Laboratory Management Association (CLMA) American Association of Clinical Chemistry (AACC) American Association of Clinical Chemistry (AACC) North Eastern Ohio Leadership AACC Leadership North Eastern Ohio AACC FirstZabaleta, OhioChair Chapter Leadership ChristineChristine Eugenio PhD, Chair Schmotzer, MD, Chair Elect Eugenio Zabaleta, PhD, Schmotzer, MD, Chair Elect MedCentral Health System UH CaseCenter Medical Center MedCentral Health System Case Medical BoardUH of Directors: Allen Nickels, President Louise Headley, Past President Lisa Kubit, Past Chair,Treasurer Program Lisa Kubit, Past Chair, Program Chair Chair Katherine Jacob, Cleveland HeartLab, Inc. Cleveland HeartLab, Inc. Rosanne Kelley, Secretary David Anderson, PhD, Treasurer David Anderson, PhD, Treasurer Six Rivers Chapter Leadership Cleveland State University Cleveland State University Sihe Wang, PhD, Delegate Sihe PhD, Delegate Pat Wang, Webster Cleveland Clinic Cleveland Clinic Jean Komraus Clive Hamlin Ed Lorson Jane Tester, President Board of Directors: Lena Alvis, Secretary Jennifer Douglas Emily Adams, President-Elect Mary Coordinator Beth Kasper Dustin Bunch, Continuing Education/Website Dustin Bunch, Continuing Education/Website Coordinator Kathy Good, Past President Richard Kuertz ClevelandCleveland Clinic Clinic With10,000 nearlymembers, 10,000 members, isJenny theinternational largest international of research With nearly AACC is AACC the largest society ofsociety research Wanda Broerman, Treasurer Murray clinical laboratory professionals, physicians, and others oriented oriented clinical laboratory professionals, physicians, researchresearch scientistsscientists and others in the of laboratory clinical laboratory 1948, the is society is in the field of field clinical medicine.medicine. FoundedFounded in 1948,inthe society Western Lake Erie Chapter Leadership headquartered in Washington, DC. members AACC members comea from variety of headquartered in Washington, DC. AACC come from varietya of employment settings: hospital labs (50%), industry (26%) and independent labs employment settings: hospital labs (50%), industry and independent labs Board(26%) of Directors: Pamela Kin, President (24%). of the membership is international. 23 local area sections (24%). 30% of 30% the membership is international. 23 local area sections and 13 and 13 Tom Bierley, President-Elect Rhonda Perry, Past President divisions focus on laboratory medicine subspecialties such as specialty specialty divisions focus on laboratory medicine subspecialties such as Point of Point of Mary Slaughter, Secretary Brad Stotz Care,Joan Pediatric Maternal Fetal, and Molecular tofew. name a few. Benya, Treasurer Karen Diagnostics, Bodeman Care, Pediatric Maternal Fetal, and Molecular Diagnostics, to name a Bonnie Van Schoik AACC’smeeting annual and meeting and exposition is often held jointly withand ASCLS AACC’s annual exposition is often held jointly with ASCLS is theand is the is an international organization whose20,000 membership is responsible for in of the field of laboratory medicine nearlyparticipants 20,000 participants and largest inlargest the CLMA field laboratory medicine attractingattracting nearly and laboratories and clinical services in hospitals, healthcare networks, group 600 exhibitors. a major publisher books and five major periodicals on 600 exhibitors. AACC is AACC a majorispublisher of books of and five major periodicals on practices andscience. independent settings. Theinternational First Ohio, Six andreviewed Western Lake clinical laboratory Clinical Chemistry is an international peer clinical laboratory science. Clinical Chemistry is an peerRivers reviewed Chapters ofjournal CLMA organizations dedicated to excellence journal is the most citedinare journal in the field. Clinical Laboratory News offers in journal and is Erie theand most cited theprofessional field. Clinical Laboratory News offers services; towith enhancing professional, managerial and leadership skills; to news stories featureand articles and viewpoints from leading clinical breaking breaking newsclinical stories with feature articles viewpoints from leading clinical promoting efficient, productive and high quality operations; advocating on behalf laboratory scientists. Clinical Laboratory Strategies addresses the essentials of laboratory scientists. Clinical Laboratory Strategies addresses the essentials of of quality patient care and chapter membership. laboratory management and mastering in laboratory In to addition to laboratory management and mastering change inchange laboratory practice. practice. In addition the AACC member website, a joint venture with ASCLS, Lab Tests Online the AACC member website, a joint venture with ASCLS, Lab Tests Online These Chapters provide education, regulatory information and networking (www.labtestsonline.org) has wone-mails severalwith awards and hosts more than 700,000 (www.labtestsonline.org) won several awards and hosts more than 700,000 opportunities. has CLMA provides the latest regulatory updates and visitors per month. For information on AACC visit www.aacc.org. visitors per month. For information on AACC visit www.aacc.org. industry trends as well as newsletters and journals to its members. This organization is an invaluable asset for current and future laboratory leaders. First Ohio-CLMA Leadership can be found at http://www.clma.org/group/FOC Western Lake Erie-CLMA Leadership found at http://www.clma.org/group/WLEC Six Rivers-CLMA Leadership can be found at http://www.clma.org/group/SRC 17 Register Early Online registration. Visit our website at: Register Early http://www.cvent.com/d/3cqcvr Online registration. Visit our website at: If you are planning to attend the conference, http://www.cvent.com/d/3cqcvr you are strongly encouraged to register If you are planning to attend the conference, before the April 26th postmark deadline in you are strongly encouraged to register th order to take advantage of the lower before the April 26 postmark deadlineearly in registration fees. After 26th,early all order to take advantage of April the lower registrants mustAfter payApril the regular/onsite fees. registration fees. 26th, all Please see the complete instructions for registrants must pay the regular/onsite fees. registration the registration Please see theadjacent completetoinstructions for form for more information. registration adjacent to the registration form for more information. Conference Registration Areas Hours Conference Registration Areas Hours On-site registration and registration check-in On-site registration will beregistration held at theand Crowne Plaza check-in Columbus willNorth be held at the Crowne Plaza Columbus during the following days and times: North during the following days and times: Wednesday, May 8 12:30 pm – 5:00 pm Wednesday, May 8 12:30 pm – 5:00 pm Thursday, May 9 8:00 am – 5:30 pm Thursday, May 9 8:00 am – 5:30 pm Friday, May 10 7:30 am – 3:30 pm Friday, May 10 7:30 am – 3:30 pm Continental Breakfast Continental Breakfast Plan to join your colleagues at the Plan to join your colleagues at the complimentary Continental Breakfast complimentary Continental Breakfast on on Thursday and Friday mornings from Thursday and Friday mornings from 8:008:00 am- am8:30 am. 8:30 am. Name Badges Name Badges A name badge must be worn by all conference attendees for admission to all sessions, the A name badge must be worn by all conference Student Academic Challenge, and all breaks attendees for admission to all sessions, the and food/social functions. Student Academic Challenge, and all breaks and food/social functions. Documentation of Continuing Education Documentation of Continuing Education ASCLS-Ohio is an approved provider of continuing education programs ASCLS-Ohio is an approved provider by of the American Society for Clinical Laboratory continuing education programs by the ® Science (ASCLS) P.A.C.E. Program. This American Society for Clinical Laboratory ® conference a wide range ofThis educational Science (ASCLS)offers P.A.C.E. Program. opportunities meet yourofcontinuing conference offers atowide range educational opportunities to requirements. meet your continuing education A “Certificate of education requirements. A “Certificate of sessions Attendance” will be validated for all Attendance” will be validated for all sessions attended. attended. Dietary/Special Accommodations Dietary/Special Accommodations If you have special needs that require If youaccommodation have special needs that require (including dietary allergies and accommodation (including dietary allergies and vegetarian), contact Laura Hook at vegetarian), contact Laura Hook at mlt_laura@yahoo.com to make appropriate mlt_laura@yahoo.com to make appropriate arrangements. Forty-eight (48) hour advanced arrangements. Forty-eight (48) hour advanced noticed is needed tomost fulfill requests. most requests. noticed is needed to fulfill SAVE THE DATE! SAVE THE DATE! OHIO 2014 COLLABORATIVE LABORATORY CONFERENCE OHIO 2014 COLLABORATIVE LABORATORY CONFERENCE th th th th May 7 7– 9– 9 May Columbus, OHOH Columbus, 18 Join Us for a Greet, Eat and Meet Night Wednesday, May 8 5:00pm – 7:00pm The Ohio 2013 Collaborative Laboratory Conference steering committee, co-chairs, and all members invite you to a social event to kick off this special conference. The Wednesday night dinner will be included with all full registrations. This is an opportunity to catch up with friends and colleagues, make new ones, and relax before the conference swings into full gear on Thursday. Please make certain to check the Wednesday dinner on your registration so that we may plan for your meal. Vendor Exhibits and Reception Thursday, May 9 Exhibits starting at 12:00pm. Reception- 5:00 pm – 7:00 pm Friday, May 10 Exhibits 9:30 am – 1:30 pm Social Event- Fun at the Lanes Thursday, May 9 8:00pm Join us Thursday after the vendor reception for our social event outside of the CLC conference. We will be going to the Columbus Square Bowling Palace at 8:00 pm for a night of bowling. Meet members of the sponsoring organizations and delve into the opportunities of the profession while kicking back with some gutter balls and friendly banter. The cost will be approximately $3.50/person/game. This price includes shoe rental. Student Academic Challenge Friday, May 10 2:30 – 5:00 p.m. The ASCLS Academic Challenge committee is looking for excited, enthusiastic MLT/MLS students to join in participating in the 10th annual Academic Challenge. (AKA: Student Bowl). To organize your team you will need three members and one or two alternates. Team members must be registered participants for the meeting in order to qualify being on a team. As last year’s winner, Southwest General will be defending their title at the competition this year. The deadline for registering your team is rapidly approaching, so get your team organized, and come join students from all around the state for an afternoon of educational FUN! Charity Opportunity – Canned Food Drive All days at Registration area Mid-Ohio Food Bank- non-perishable food and monetary donations will be accepted on-site or visit the link below and select the CLC 2013 button: http://fooddrive.midohiofoodbank.org/site/TR/FundraisingEvent/General?px=1044441&pg=personal&fr_id =1140 19 outside with some of the latest Chemistry, Hematology andwith Immunoassay outside some of theinstruments. latest Chemistry, Hematolo The exhibit hall will give you the opportunity to talk The to numerous representatives from exhibit hall will give you the opportunity to talk t the different companies, so you can compare the pros and conscompanies, of different so systems, the different you canallcompare the pr at the same time. at the same time. Each year these vendors help sponsor the Clinical Each Laboratory Conference. play a the Clinical L year these vendors They help sponsor significant role in sponsoring speakers, breaks, andsignificant lunches, role helping to make it possible in sponsoring speakers, breaks, and for us to put on the caliber of conference we do each year. Please take time during the for us to put on the caliber of conference we do eac conference to visit with them, learn about new laboratory products, make great to visit with them, learn about new labor The Collaborative Laboratory Conference for 2013conference will have many vendors present connections and thank them for their support. connections and thank them for again, to show us Laboratory what’s new Conference in our field. for There willwill behave demonstration vanspresent parkedtheir support. The Collaborative 2013 many vendors outsidetowith some of the latest Hematology Immunoassay again, show us what’s new inChemistry, our field. There will be and demonstration vansinstruments. parked Vendors that we will be seeing include: The exhibit hall will give you the opportunity to talk to numerous representatives outside with some of the latest Chemistry, Hematology and Immunoassay Vendors that we will be instruments. seeingfrom include: the different companies, so you comparetothe and cons representatives of different systems, The exhibit hall will give you the can opportunity talkpros to numerous from all at the same time. the so you can compare the pros and cons of different systems, all •different ARUPcompanies, Laboratories • ARUP Laboratories at the same time. • Beckman Coulter • Beckman Coulter They play a Each year these vendors help sponsor the Clinical Laboratory Conference. • year BD these significant role invendors sponsoring breaks, andLaboratory lunches, to make it possible Each helpspeakers, sponsor the Clinical Conference. They play a • BD helping for us to put on the caliber of conference we do each year. Please take time during the significant role in sponsoring speakers, breaks, and lunches, helping to make it possible • Instrumentation Laboratories • Instrumentation Laboratories conference them, learn aboutwe new maketime great for us to putto onvisit the with caliber of conference dolaboratory each year.products, Please take during the • LabCorp connections their support. conference toand visitthank with them them,for learn about new laboratory products, make great • LabCorp connections and thank them for their support. • M.S. Stegall & Associates • M.S. Stegall & Associates Vendors that we will be seeing include: • Ortho-Clinical Diagnostics Inc. • Ortho-Clinical Diagnostics Inc. Vendors that we will be seeing include: •• Roche ARUP Laboratories • Roche •• ARUP Laboratories RROS iScrHoc Healthcare Beckman Coulter • RROS iScrHoc Healthcare •• Beckman Coulter Siemens Diagnostics BD •• BD Siemens Water Laboratories Instrumentation •• Instrumentation Laboratories Sysmex LabCorp • Siemens Diagnostics • Siemens Water • Sysmex •• LabCorp W.E.L. Instrument Company M.S. Stegall & Associates • W.E.L. Instrument Company •• M.S. Stegall & Diagnostics Associates Inc. And many others Ortho-Clinical • And many others The sponsoring organizations would •• Ortho-Clinical Diagnostics Inc. Roche like to thank you for your support. We are looking forward to our annual Vendor Reception, weforward can have a cocktail We arewhere looking to our annual Vendor Recep • Roche Welcome to the 2012 Collaborative RROS iScrHoc Healthcare and•appetizers with them and be able to do some serious networking. and appetizers with them and be able to do some se Laboratory Conference! •• RROS iScrHoc Healthcare Siemens Diagnostics •• Siemens Siemens Diagnostics Water The sponsoring organizations would •• Siemens Water like to thank you for your support. Sysmex Welcome to the 2012 Collaborative •• Sysmex W.E.L. Instrument Company The sponsoring organizations would Laboratory Conference! like to thank you for your support. •• W.E.L. Instrument Company And many others • And many others The sponsoring organizations would Welcome to the 2012 2013 Collaborative to thankforward you for to your We like are looking oursupport. annual Vendor Reception, where we can have a cocktail to with the 2012 andWelcome appetizers them and be ableVendor to do Conference! some seriouswhere networking. Laboratory We are looking forward toCollaborative our annual Reception, we can have a cocktail Laboratory Conference! and appetizers with them and be able to do some serious networking. 20 Ohio CLC 2013: An Exploration of Medical Laboratory Science Guest rooms have been reserved at the Crowne Plaza for the nights of Tuesday May 7th to Thursday, May 9th with a special rate of $89.00 per night, plus applicable taxes (king bed or double beds) for conference attendees. These group rates are available until April 26th or they run out of rooms so be sure and book early! To book a room at the Crowne Plaza - call the Crowne Plaza at 1-614-885-1885. State when making your reservation that you are attending the Ohio Collaborative Laboratory Conference (CLC) and note that the group code is LAB CBL (group code must be used when making reservations). Crowne Plaza, Columbus North 6500 Doubletree Ave Columbus, Ohio 43229 (614) 885-1885 FROM CLEVELAND AND POINTS NORTH EAST: I-71 South to Exit 117. Take the right and follow signs for OH-161.Turn right onto OH-710 North/ Busch Blvd. Turn right onto Kingsmill Pkway. Arrive at 6500 Doubletree Ave. FROM CINCINNATI: Take I-71 North toward Columbus. Take the ramp right for I-70 East/ I-71 North toward Cleveland. At Exit 101A take ramp left for I-71 North to Cleveland. At exit 117 take ramp right and follow signs for OH-161.Turn left ontoOH-161W/E Dublin Granville Rd. Turn right onto OH-710 North/ Busch Blvd. Turn right onto Kingsmill Pkway. Arrive at 6500 Doubletree Ave. FROM THE WEST: Take I-70 East toward Columbus. Keep left onto I-670 East. At exit 5B take ramp left for I-71 North toward Cleveland. Keep left onto I-71 South. At exit 117 take the right and follow signs for OH-161.Turn left onto OH-161W/E Dublin Granville Rd.Turn right onto OH-710 North/ Busch Blvd. Turn right onto Kingsmill Pkway. Arrive at 6500 Doubletree Ave. 21 General GeneralRegistration Registration On-line On-lineregistration registrationand andcredit creditcard cardpayment. payment.Check Checkout outthe thewebsite websiteatathttp://www.cvent.com/d/3cqcvr. http://www.cvent.com/d/3cqcvr. The Theconference conferenceregistration registrationfee feeincludes includesadmission admissiontotoscientific scientificsessions, sessions,refreshment refreshmentbreaks, breaks,lunch, lunch,dinner dinnerand and the thevendor vendorsponsor sponsortables. tables.Lunch Lunchrequires requiresa aticket ticketthat thatwill willbe beprovided providedininyour youronsite onsiteregistration registrationpacket. packet.Dinner Dinner Wednesday Wednesdaynight nightwill willalso alsobe beincluded includedwith witha afull fullregistration registrationororWednesday Wednesdayonly onlyregistration. registration.Please Pleasebe besure suretoto mark markwhether whetherorornot notyou youplan plantotoattend attendon onyour yourregistration registrationform. form.It Itisisvery veryimportant importanttotonote noteon onthe theregistration registration form formwhat whatsessions sessionsyou youexpect expecttotobe beattending attendingtotoensure ensureadequate adequateseating. seating.Do Donot notselect selectmore morethan thanone one session sessionscheduled scheduledatatthe thesame sametime. time.Some Somesessions sessionswill willbe belimited limitedtotoa amaximum maximumseating seatingofof30 30people. people. Dietary Dietary/Special /SpecialAccommodations Accommodations If Ifyou youhave haveany anydietary dietaryrestrictions restrictionsororvegetarian vegetarianneeds, needs,please pleasecontact contactLaura LauraHook Hookatatmlt_laura@yahoo.com mlt_laura@yahoo.com prior priortotothe theconference conferencetotoensure ensureadequate adequatetime timefor fora alunch lunchtotobe beprepared. prepared. Attention: Attention:Members Membersof ofAACC, AACC,ASCLS, ASCLS,CLMA CLMA When Whencompleting completingthe theconference conferenceregistration registrationform, form,please pleasecheck checkthe theappropriate appropriatemember memberbox(es) box(es)– –and andprovide provide your yourmember membernumber numberfor foreach. each.This Thiswill willensure ensurethat thatyour yourstatus statusasasa amember memberofofone one(or (ormore) more)ofofthe the collaboration collaborationorganizations organizations(AACC (AACC– –Northeast NortheastOhio OhioSection, Section,ASCLS-Ohio, ASCLS-Ohio,CLMA–First CLMA–FirstOhio, Ohio,Six SixRivers Riversoror Western WesternLake LakeErie ErieChapter) Chapter)isisrecognized recognizedand andmember memberregistration registrationfees feeswill willapply. apply.Your Yourcurrent currentmembership membership status statusininthe theorganization(s) organization(s)selected selectedwill willbe beverified. verified. Institutional InstitutionalRegistration Registration Badges Badgesmay maybe bepurchased purchasedtotoenable enableseveral severalemployees employeesfrom froman aninstitution institutiontotoattend attendselected selectedsessions sessionsduring during the theconference conferencewithout withouteach eachperson personneeding needingtotoregister registerfor fora asingle singleday. day. The Theprice priceofofthe theinstitutional institutionalbadges badgesisis$250 $250for forthe thefirst firstbadge badgeand and$175 $175for foreach eachadditional additionalbadge badgepurchased purchasedbyby the theearly earlyregistration registrationdeadline. deadline.The Thebadges badgesmay maybe betransferred transferredasasdesired desiredtotoallow allowmaximum maximumparticipation. participation.One One lunch lunchticket ticketwill willbe beprovided providedon onThursday Thursdayand andFriday Fridayfor foreach eachbadge badgepurchased. purchased. Please Pleaseprovide providethe thename nameofofa acontact contactindividual individualfor forany anyquestions questionsconcerning concerningthe theinstitutional institutionalregistration registrationand andtoto obtain obtaina alisting listingofofthose thoseindividuals individualswho whowill willbe beusing usingthe thebadges badgesand andthe thesessions sessionsthey theywill willbe beattending. attending.To To assist assistwith withthe thescheduling schedulingofofstaff staffwho whowill willbe beattending attendingthe theconference conference(and (andtotosubmit submitwith withthe theregistration registrationform form rkelley@ccf.orgtotorequest requestan anelectronic electroniccopy copyofofthe the ororvia viaemail), email),please pleasecontact contactRosanne RosanneKelley Kelleyatatrkelley@ccf.org “Institutional “InstitutionalBadge BadgeUsers UsersSession SessionSelection SelectionWorksheet”. Worksheet”. Sorry, Sorry,no noon-site on-siteregistration registrationisisavailable availablefor forinstitutional institutionalbadges. badges. Early EarlyRegistration Registration Early Earlyregistration registrationMUST MUSTbe beentered enteredon-line on-lineororif ifmailed, mailed,postmarked postmarkedon onororbefore beforeApril April26, 26,2013. 2013.After Afterthis thisdate, date, the thehigher higheron-site on-sitefees feesapply. apply. Refund/ Refund/Cancellation Cancellation Policies Policies Full Fullregistration registrationfees feeswill willbe berefunded refundedonly onlyif ifa awritten writtenrequest requestisispostmarked postmarkedon onororbefore beforeApril April26, 26,2013. 2013.AA session sessionmay maybe becancelled cancelledif ifthere thereisisinsufficient insufficientinterest interestfrom fromregistrants. registrants. Questions Questions/ /Need NeedMore MoreInformation? Information? Melanie MelanieGiusti, Giusti,Co-Chair: Co-Chair:melanie.giusti@uc.edu melanie.giusti@uc.edu Allen AllenNickels: Nickels:nickelsa@summahealth.org nickelsa@summahealth.org Dustin DustinBunch, Bunch,Co-Chair: Co-Chair:bunchd@ccf.org bunchd@ccf.org Stacy StacyBaker: Baker:stacylacy2@columbus.rr.com stacylacy2@columbus.rr.com Catherine JaneTester: Tester:jane.l.tester@questdiagnostics.com jane.l.tester@questdiagnostics.com CatherineShaffner: Shaffner:catherine.shaffner@promedica.org catherine.shaffner@promedica.org Jane Pam PamKin: Kin:pamela_kin@mhsnr.org pamela_kin@mhsnr.org 22 Eugenio EugenioZabaleta: Zabaleta:ezabaleta@medcentral.org ezabaleta@medcentral.org Registration Form See See our our website website for for online online registration registration at: at: http://www.cvent.com/d/3cqcvr http://www.cvent.com/d/3cqcvr Name Name ________________________________________________ ________________________________________________ MEMBERSHIP: Check all that apply (include member # Institution Institution _____________________________________________ _____________________________________________ AACC, NEO-Member # _____________________ Registration Form See our website for online registration at: http://www.cvent.com/d/3cqcvr Mailing Mailing Address Address ________________________________________ ________________________________________ Name ________________________________________________ City City // State State // Zip Zip Code Code ___________________________________ ___________________________________ Institution _____________________________________________ Phone: (Day) _________________ (Evening) Phone: (Day) _________________ (Evening) _________________ _________________ Mailing Address ________________________________________ Email _________________________________________ Email _________________________________________ City Address: /Address: State / Zip Code ___________________________________ Are you member of or N Y Are you aa(Day) member of AACC, AACC, ASCLS, ASCLS, or CLMA CLMA N Phone: _________________ (Evening) _________________ Are Are you youAddress: aa student? student? N Y N Y Email _________________________________________ Are you a member of AACC, ASCLS, or CLMA Are you a student? Registration Registration Fees: Fees: N Y N Y Postmark Postmark by April 26 Full Registration Registration (Wed,Thurs,Fri) (Wed,Thurs,Fri) Full Registration Fees: Member Member Postmark by April 26 AACC, NEO-Student # _____________________ ASCLS-Ohio # _____________________ MEMBERSHIP: Check all that apply (include member # AACC, NEO-Member # _____________________ AACC,Professional NEO-Student # #_____________________ _____________________ Student ASCLS-Ohio # #_____________________ _____________________ st st CLMA-1 Professional Ohio CLMA-WLE Student N/A # _____________________ N/A # _____________________ st CLMA-1 Rivers CLMA-Six Ohio N/A N/A CLMA-WLE N/A CLMA-Six Rivers N/A After April 26 After April 26 $170.00 $170.00 $220.00 $ __________ $245.00 $245.00 $295.00 $ __________ Student Member Member Student $70.00 $70.00 $120.00 $ __________ Student Nonmember Nonmember Student $100.00 $100.00 $150.00 $ __________ Institutional, First Badge Badge Institutional, First Student Nonmember $250.00 $250.00 $100.00 $300.00 $150.00 $ $__________ __________ $175.00 $225.00 $ __________ Full Registration (Wed,Thurs,Fri) Nonmember Nonmember Member $170.00 Nonmember $220.00 $245.00 Student Member $295.00 $70.00 Institutional, Each Additional Badge Institutional, Badge Institutional,Each FirstAdditional Badge # Additional Badges =Dinner _______ Wednesday Collaboration Dinner Wednesday Collaboration Please let us know if you plan to attend attend Please let us know if you plan to Wednesday Collaboration Dinner $ __________ $120.00 $175.00 $175.00 $250.00 AdditionalEach Badges _______ ## Additional Badges == _______ Institutional, Additional Badge $ __________ $ __________ $225.00 $300.00 YES, YES, II will will attend YES, I will attend Please let us know if you plan to attend Wednesday Only Wednesday Only Wednesday Only Member $75.00 Member $75.00 $ $__________ __________ NO, I will not attend NO, I will not attend $100.00 Wed. registration $ __________ Member Nonmember Nonmember $75.00 $105.00 $105.00 Student Member Member Student $35.00 $35.00 $60.00 $ __________ Student Nonmember Nonmember Student $45.00 $45.00 $70.00 $ __________ Member Member Member $90.00 $90.00 $90.00 $130.00 $130.00 $ $__________ __________ Student Member Student StudentMember Member $35.00 $35.00 $35.00 $60.00 $60.00 $ $__________ __________ Nonmember $100.00 $130.00 Wed Dinner included in full or Wed. Wedregistration Dinner included in full or $105.00 Student Member $130.00 $35.00 Student Nonmember $60.00 $45.00 Thursday only only or or Friday Friday only only Thursday $70.00 __________ $ $__________ $ __________ $ __________ $ __________ Thursday only or Friday only ((Please Please day(s) day(s) attending attending –– fees fees are are each each day) day) (Please day(s) attending – fees are each day) Nonmember Nonmember Nonmember $125.00 $125.00 $125.00 Student Nonmember Student StudentNonmember Nonmember $165.00 $165.00 $55.00 $55.00 $55.00 $80.00 $80.00 $ $__________ __________ $ $__________ __________ TOTAL $ $___________ ___________ TOTAL PleaseCIRCLE CIRCLEthe thesessions sessionsyou youplan planto attend: Please Please CIRCLE the sessions you plan totoattend: Payment:by bycheck check Payment: Wednesday Wednesday Wednesday W1 W2 W2 W3 W3 W4 W4 W5 W5 W6 W6 W7 W7 W8 W8 W9 W9 W1 W1 W2 W3 W4 W5 W6 W7 W8 W9 Thursday Thursday Thursday T10 T11 T12 T13 T14 T15 T16 T17 T18 T19 T10 T10 T11 T11 T12 T12 T13 T13 T14 T14 T15 T15 T16 T16 T17 T17 T18 T18 T19 T19 Card: VISA VISA Master Card Am Am Express Card: Master Card Express Card Number: ______________________________ Card Number: ______________________________ Expiration Date: _________________ Expiration Date: _________________ You can also register online at: You can also register online at: http://www.cvent.com/d/3cqcvr T20 T20 T20 T21 T21 T21 T22 T22 T22 T23 T23 T23 T24 T24 T24 T25 T25 T25 T26 T26 T26 T27 T27 T27 T28 T28 T28 T29 T29 T29 Friday Friday Friday F30 F31 F32 F33 F34 F35 F36 F37 F38 F39 F30 F30 F31 F31 F32 F32 F33 F33 F34 F34 F35 F35 F36 F36 F37 F37 F38 F38 F39 F39 F40 F41 F42 F43 F44 F45 F46 F47 ASCLS-Ohio Member F40 F40 F41 F41 F42 F42 F43 F43Meeting F44 F44 (Friday) F45 F45 F46 F46YesF47 F47 Academic Challenge ASCLS-Ohio ASCLS-Ohio Member Member Meeting Meeting Yes (Friday) (Friday) Yes Yes Academic Academic Challenge Challenge Yes Yes F48 No F48 F48 No No F49 F49 F49 creditcard card bybycredit http://www.cvent.com/d/3cqcvr Make Check payable to: ASCLS-Ohio – CLC 2013 Make Check payable to: ASCLS-Ohio – CLC 2013 Mail registration form and payment to: Mail registration form2013 and payment to: ASCLS-Ohio – CLC ASCLS-Ohio – CLC 2013 c/o Catherine Shaffner c/o Catherine Shaffner 10204 N Shannon Hills Ln Perrysburg, OhioHills 43551-2691 10204 N Shannon Ln Perrysburg, Ohio 43551-2691 23 April 25 – 27, 2012 2011 CLC Organization Logos 2011 CLC Organization Logos Columbus, Ohio Crowne Plaza North PLEASE CIRCULATE Tiffin. OH 44883 ASCLS Ohio 2009 Education Conference ASCLS-Ohio 10204 N Shannon Hills Lane Pam Kin Perrysburg, Ohio 43551 45 St. Lawrence Dr. bora2013 tivOhio e Collaborative LaborLaboratory atorConference y ab Conference Ohio 2012 PRESORTED FIRST CLASS US POSTAGE PAID TOLEDO OH PERMIT 339
